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RELIABILITY AND RESPONSIVENESS OF PHYSICAL ACTIVITY MEASURES IN 
INDIVIDUALS AFTER TOTAL KNEE ARTHROPLASTY 
Gustavo J. Almeida, PhD 
University of Pittsburgh, 2015 
Few instruments that measure physical activity (PA) can accurately quantify PA performed at both 
light and moderate intensities, which is particularly relevant in older adults. Evidence of their 
reliability and responsiveness to change is limited. The purposes of this study were to: 1) determine 
test-retest reliability of the Actigraph (ACT), SenseWear Armband (SWA) and the Community 
Healthy Activities Model Program for Seniors (CHAMPS) questionnaire in assessing free-living PA; 
and 2) determine the responsiveness to change in PA measured by the three instruments after an 
exercise program in individuals with knee osteoarthritis who underwent total knee arthroplasty 
(TKA).  
Test-retest reliability was determined by asking subjects to wear the activity monitors for two 
weeks and complete the CHAMPS at the end of each week. Reliability was measured using intra-
class correlation coefficients (ICC2,k). For responsiveness, subjects wore the activity monitors for 
one week at baseline and at 6-months, and completed the CHAMPS at the end of each week. 
Changes in PA and standardized response mean (SRM) were calculated and compared across 
instruments. Weighted-Kappa (K) was used to determine agreement between the instruments on 
identifying changes in PA based on measurement error. 
Test-retest reliability ranged from moderate to excellent for ACT (ICC=0.75-0.86), and were 
excellent for SWA (ICC=0.93-0.95) and CHAMPS (ICC=0.86-0.92) in the subjects who reported 
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similar PA during two-weeks. The 95% confidence interval of the ICCs from SWA was the only one 
within excellent reliability range (0.85-0.98). Results for responsiveness revealed small and not 
statistically significant changes in PA (p>0.05) measured by each instrument after the intervention. 
SRMs indicated small degree of responsiveness (SRM=0.01-0.26). When using each instruments’ 
measurement error as a threshold for change in PA, the ACT and SWA agreed on the identification 
of changes in PA (K=0.36-0.63) and disagreed with the CHAMPS (K≤0.22). 
This study provides evidence that the ACT and SWA have better psychometrics than the 
CHAMPS, and amongst the activity monitors, the SWA showed better psychometrics. Clinicians 
and researchers can use the results from our studies to make well-informed decisions when selecting 
instruments to measure free-living PA in individuals with arthritis of the lower extremities.  
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1.0 CHAPTER 1 - RESEARCH PROPOSAL 
1.1 INTRODUCTION 
Individuals who undergo total knee arthroplasty (TKA) are generally older adults with end-stage 
knee osteoarthritis, who have dealt with pain and functional limitations for a long period of time. 
Because of these factors, they tend to acquire an inactive lifestyle prior to the surgery.1,2 Although 
TKA clearly relieves knee pain and improves functioning in the majority of individuals,3-5 they keep 
their sedentary behavior after surgery.1 It is known that 60% of them do not meet physical activity 
(PA) recommendations and around 1/3 are obese,2  which puts them at risk for further disability and 
chronic diseases. Therefore, improving PA is important in this population and accurately measuring 
changes in PA in research aimed at promoting a more active lifestyle for these individuals is 
essential. But before PA can be used as the primary outcome in individuals after TKA, it is 
important for researchers to know how reliable and responsive the available instruments to measure 
PA are. It is equally important to compare the reliability and responsiveness of commonly used 
instruments to measure PA in this population, which has not been done before. Investigating and 
comparing the reliability and responsiveness of commonly used instruments to measure PA will 
inform the selection of instruments to use and the interpretation of observed changes in measures of 
PA in research studies. 
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1.2 PSYCHOMETRICS OF PA MEASURES IN INDIVIDUALS WITH KNEE 
OSTEOARTHRITIS WHO UNDERWENT TKA 
1.2.1 Investigating Reliability of Measures of PA after TKA 
Reliability is the consistency of a score or measurement. The Standards for Educational and 
Psychological Testing define reliability as “the consistency of measurements when the testing 
procedure is repeated on a population of individuals or groups”.6 Reliability is the extent to which 
the same results are obtained on repeated administrations of the same test or measure when no 
change has occurred in the construct being measured.7,8 Measures of PA should be reliable if they 
ought to be used in research and clinical practice to evaluate ongoing progress in a treatment 
situation. Without reliability, it is not viable to determine whether the instruments used to measure 
PA are accurately and consistent.  
Estimates of reliability determine how much of the variability in test scores is due to errors 
in the measurement and how much is due to variability in true scores.9 The concept of measurement 
error is at the heart of reliability. When one measures a construct, the true score is never known and 
it must be estimated from the observed score, which provides imperfect information. Calculating an 
index of reliability requires quantifying the measurement error associated with the observed score. 
The observed score is composed of the true score and the error score. A true score is the replicable 
feature of the concept being measured. It is the part of the observed score that would recur across 
different measurement occasions in the absence of error. However, random error is always present 
in a measurement and it represents the discrepancies between scores obtained on tests and the 
corresponding true scores. 10 Random error is easily recognized when assessments are used 
 3 
 
repeatedly on stable individuals and the observed scores are not the same on each repeated 
assessment. Random error arises from multiple sources. Some examples of random error in 
measures of PA are the inherent unpredictable fluctuations in the measurements provided by 
devices or the variable perception of the amount of activity one performs and reports in self-
reported questionnaires. 
There are several forms of reliability estimates. To test the reliability of PA measures, it 
would be appropriate to use the test-retest approach. The test-retest reliability assesses the degree to 
which test scores are consistent from one test administration to the next at two different points in 
time during which the construct being measured is believed to be stable. 11 This kind of reliability is 
used to assess the consistency of a test across time. Test-retest is appropriate to be used in measures 
of PA because time is believed to be the major source of error in this measure. People tend to vary 
their PA behavior across time and this inherent variability can affect the estimates of reliability. 
There are also several indexes to determine test-retest reliability. One such index is the Intraclass 
Correlation (ICC) coefficient. The ICC is a reliability coefficient designed for use with interval/ratio 
data, and it is calculated using variance estimates obtained through an analysis of variance. 12 The 
coefficients range from 0 to 1, with higher values representing better reliability. According to 
Fitzpatrick et al, a good test-retest reliability coefficient should be 0.70 or higher if the measure is to 
be used to evaluate the ongoing progress of an individual in a treatment situation. 11  
 To determine the error associated with the measurements of PA is also important. It helps 
to establish thresholds for interpreting true changes in PA between two assessments. Changes 
greater than measurement error help assure that measured changes are due to an individuals’ change 
and not due to the error inherent to the instrument. The standard error of the measurement (SEM) 
is a common coefficient of measurement error. The SEM is useful when interpreting change 
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because it is calculated in the same unit as the measure. In the proposed study, we used the ICC and 
the index of test-retest reliability and determined measurement error by using the SEM.   
 Reliability is also a critical component of responsiveness. Measures with poor reliability are 
likely to be less responsive because the noise introduced by the error might obscure any real change 
that has occurred. To date, studies have not determined the reliability or measurement error of PA 
measures during light intensity activities, nor have compared these psychometric properties between 
portable activity monitors and self-reported questionnaires commonly used in older adults.  
1.2.2 Investigating Responsiveness of Measures of PA after TKA 
Another important aspect of the psychometrics of instruments is the responsiveness of the 
measurement. Responsiveness evaluates the ability of a measure to accurately detect changes in the 
concept being measured when change has occurred.7,13  Some methods of responsiveness include 
internal and external methods.14 Internal responsiveness characterizes the ability of a measure to 
change during a pre-specified time frame. In internal responsiveness method, the primary interest is 
in the measure itself and its distribution of change or magnitude of change over time. Internal 
responsiveness is often examined by administering a measure before and after a treatment of known 
efficacy within the context of randomized clinical trials or repeated measures designs. Internal 
responsiveness can be quantified by indices such as effect size, the standardized response mean and 
the Guyatt Responsiveness Index.15,16 Since internal responsiveness is based on mean changes, it is 
used to evaluate changes over time for the overall group of subjects. External responsiveness reflects 
the extent to which changes in a measure relate to changes in other measures of health status (e.g., 
global rating of change). The external responsiveness method is used to establish clinically 
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meaningful levels of change when the external reference identifies change (improvement) that is 
perceived as important to the individual.14 Therefore, external responsiveness is useful to evaluate 
changes over time for individual individuals. In this case, choosing an appropriate external measure 
is imperative.  
 To the best of our knowledge, studies have not investigated the internal or external 
responsiveness of measures of PA performed at light intensity derived from portable monitors and 
self-reported questionnaires and have not compared the responsiveness indices across measures of 
PA from portable monitors and questionnaires. 
1.3 INSTRUMENTS TO MEASURE PA  
The reference standard methods to measure PA are the Doubly Labeled Water (DLW), the 
metabolic chamber (room calorimeter) and the indirect calorimeter. DLW is used to measure PA 
during a free-living situation whereas the other methods are used to measure PA in a more confined 
environment. Methods that measure PA in free-living conditions are preferred when investigating 
changes in PA because the person is not restricted to a particular environment and can perform daily 
tasks at their usual pace and in their natural condition. Although DLW is the reference standard to 
measure PA in free-living conditions, this method is not practical for use in large scale due to its very 
high cost (≅ $1000.00 per subject per time point) and it needs an experienced person to implement 
and interpret the results. Due to the practical limitations of DLW, additional instruments have been 
developed to measure free-living PA in large-scale research. These include self-reported 
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questionnaires and portable activity monitors. These instruments are more affordable than DLW 
and do not require high technical expertise. Yet, none of them is free of flaws.  
In individuals after TKA, PA has been traditionally measured by self-reported 
questionnaires.1 Advantages of self-reported questionnaires include low price, ease of administration, 
and the ability to address the frequency, intensity, duration and types of PA such as sports, leisure, 
recreational, and occupational activities.17 Disadvantage of self-reported questionnaires of PA include 
inconsistent subject recall, overestimation of PA, and underestimation of sedentary pursuits. These 
inconsistencies have resulted in inadequate psychometrics.18 
To overcome the limitation of self-reported measures of PA, portable activity monitors, 
such as pedometers, heart rate monitors, and accelerometers, have been developed over the past 
decades to collect real-time PA information. Advantages of portable activity monitors include ability 
to measure PA in real-time during free-living conditions, and better accuracy than self-reported 
instruments in estimating energy expenditure. Portable activity monitors are more affordable 
(monitor ≅$249.00, and software ≅$1000.00) than DLW and the same device can be used for several 
subjects. Disadvantage of these monitors include the high price compared to questionnaires and the 
relative complexity of data processing. 
Pedometers and accelerometers are the portable PA monitors most used in research in older 
adults. Pedometers are the least expensive of the portable monitors, are easy to use, and can provide 
feedback regarding step counts during ambulatory activity such as walking or running. These 
monitors count the number of steps taken by using a horizontal spring suspended lever arm that 
moves up and down in response to vertical accelerations of the hip. This motion opens and closes 
an electrical circuit that accumulates the number of steps taken and provides a digital display. 
However, the use of pedometers in measuring PA in older adults has limitations such as 
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underestimation of steps taken at slower gait speeds 19-21 or with irregular and unsteady gait patterns; 
19,20,22-24 and inaccuracy in capturing seated activity, upper-extremity activity, or indoor and outdoor 
household chores such as pushing, lifting, or carrying objects. 25-28 Another limitation includes the 
nonexistence of internal clocks, which makes them unable to provide information on the duration of 
activities. Additionally, they do not take into account the intensity of vertical displacement, which 
would be needed to differentiate activity intensity level, i.e. between walking and running.  
Accelerometers overcome many of the limitations of pedometers. Accelerometers are small 
electronic sensors able to measure and store real-time estimates of the frequency, intensity, and 
duration of free-living PA.29,30 They are able to provide such information because they have an 
imbedded internal clock. These monitors measure movement through body acceleration.31,32 
Acceleration is the change in speed in relation to time. Typically, acceleration is measured in 
gravitational units (g’s) where 1 g is equal to 9.8 m.s-2. Accelerometers take into account the 
intensity of displacement and are able to differentiate the intensity of the activity (e.g., light versus 
moderate intensity). Accelerometers integrate a filtered digitized acceleration signal over user 
specified time interval called epoch. 33 One minute epoch lengths are often used for measuring PA in 
adults. Data on acceleration are recorded while the individual is wearing the accelerometer and then 
processed by software on the computer. Accelerometers can be worn on the wrist, upper arm, waist, 
low back, or ankle, attached by belts, pouches, belt clips, or Velcro bands. Those worn on the waist, 
hip or low back are well suited for capturing accelerations during normal ambulatory movement. 31,33-
35 Accelerometer-based monitors worn on the arm are able to capture body acceleration during 
ambulatory activities and activities that do not involve ambulation such as weight lifting, mopping 
and biking. These activity monitors can also monitor movements in different planes. Uniaxial 
monitors record vertical acceleration in one plane, biaxial monitors record vertical and horizontal 
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acceleration in two planes, and triaxial monitors’ record acceleration in three planes by three 
different accelerometers positioned internally at 90 degrees from one another. The output from 
triaxial accelerometers is a composite value of all three accelerometers, which is believed to provide 
a better indicator of overall body movements. In summary, accelerometer-based monitors are the 
most used in field-based research and are considered the best choice amongst the portable objective 
monitoring devices.   
1.3.1 Importance of Measuring PA at Light Intensities 
To date, most of the self-reported PA questionnaires and PA portable monitors have measured PA 
at moderate (e.g. brisk walk) or higher intensity levels (e.g. running). The interest in measuring PA at 
moderate or higher intensities is rooted in findings that health benefits are acquired when more time 
is spent in activities performed at moderate or higher intensities. 36 According to the PA guidelines 
issued by the US Department of Health and Human Services in 2008, 32 major health benefits from 
PA require the performance of at least 150 min (2.5hr) of moderate-intensity aerobic activity each 
week.  
Older adults with TKA are usually sedentary and perform most of daily activities at light 
intensities. 5 Therefore, measuring PA only at moderate or higher intensities in this population may 
not be sensitive to capture clinically important changes in PA due to interventions that intend to 
promote PA. For example, if the baseline level of PA of an individual is very low (e.g., daily activity 
consists of 30 min of slow walking inside the house to perform basic ADLs), a clinically important 
change in PA due to intervention could represent doubling the PA (e.g., the same 30 min of slow 
walking inside the house plus 30 min of slow walking outside). This change, although seems 
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important, would not be captured by instruments that measure PA at moderate or higher intensities 
only, because the person walks slow, which an activity of light intensity. Being able to walk more 
may be the first important progress towards increasing PA to a point that impacts overall health. We 
believe that measuring PA performed at light intensities after TKA is clinically relevant, and may 
allow identification of changes in PA that are beneficial to this population. The PA guidelines also 
report that there is no minimum PA threshold bellow which there is no health benefits.32   
In this study we proposed to determine the reliability and responsiveness of PA measured at 
light and moderate intensities, using both self-reported and real-time accelerometer-based monitors. 
To that end, in the next sessions of this document we discuss the rational for the choice of 
instruments to measure PA after TKA that were used in the proposed study. 
1.3.2 Choice of Self-reported Questionnaire to Measure PA after TKA 
Most of the self-reported questionnaires available to measure PA were developed and tested in 
young adults, and were designed to measure activities at moderate or high intensities (i.e. jogging, 
running and/or vigorous sports activities).37,38 As individuals after TKA are often sedentary older 
adults, who perform most activities at light intensities (e.g., slow walking, light household chores and 
gardening), questionnaires used to identify patterns of PA in this population have to be able to 
capture activities that are relevant to older adults. Only a few questionnaires have been developed to 
capture activities pertinent to older adult and they include the Physical Activity Scale for the Elderly 
(PASE), the Yale Physical Activity Survey (YPAS), and the Community Healthy Activities Model 
Program for Seniors (CHAMPS). 
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The PASE, was developed to measure age-specific PA levels of older adults.39,40 It queries 
subjects about the type and amount of PA during the past 7 days. Subjects provide information 
about the time spent (hr/week) in activities such as light/heavy housework, home repairs, lawn work 
or yard care, outdoor gardening, caregiving, work for pay or as volunteer. These data are then 
converted into a total score that ranges from 0-315 units, based on the weight of each activity (time 
spent * PASE weight). The measurement unit on PASE is aleatory and does not represent energy 
expenditure. While the PASE has been shown reliable when administered twice in an interval from 3 
to 7 weeks (r= 0.84),39 its validity is questionable when comparing its PA measures to the measures 
from the reference standard of DLW (r= 0.28). 41 Additional limitations of this instrument is that it 
does not differentiate light from moderate intensity activities and its score cannot be directly 
compared with data on energy expenditure provided by portable activity monitors. 
The YPAS was developed to measure age-specific PA of older adults in a typical week in the 
past month.42 The YPAS evaluates activities across varying types, including household, recreational, 
and exercise settings. The survey provides three summary indices and five subscales. The three 
indices include the Total Time Summary Index (TTSI), the Energy Expenditure Summary Index 
(EESI), and the Activity Dimensions Summary Score (ADSS). The TTSI, which calculates total time 
spent for each activity on the checklist, is expressed as hr/week. The EESI is expressed as 
kilocalories per week (kcal/week) and represents the time spent on each activity multiplied by an 
intensity code and is summed over all activities. The YPAS has shown moderate test-retest 
reliability, with correlation coefficients of its indices ranging from 0.42 to 0.65. However, its validity 
is questionable. The correlation of total energy expenditure during PA calculated by the YPAS and 
the reference standard of DLW was poor (r = 0.07 to 0.11).41,43 Similar to the PASE, the YPAS does 
not provide a simple way to distinguish scores from light to moderate intensity activities. 
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One more instrument developed to be used in older adults is the CHAMPS. 44,45 The 
CHAMPS was originally developed to be used as an outcome measure of a PA promotion 
intervention and it measures PA in a typical week in the past month. Subjects provide information 
on type and frequency of 41 activities of several intensity levels. From the questions, measures of 
frequency per week and estimated kcal/week in PAs are derived. For both frequency and caloric 
expenditure, two measures are derived based on: (1) PAs of moderate or greater intensity (metabolic 
equivalent [MET] value above 3.0), and (2) all specified PAs that include activities of light intensity 
in addition to moderate and greater. Thus, estimated caloric expenditure measures are calculated by 
multiplying the estimated duration of each activity by the MET value (i.e., weighting the time spent 
by the intensity) and summing these across all relevant activities. Then, by simply subtracting the 
values of moderate or greater intensity from all specified PAs, values of light intensity activities are 
generated. The CHAMPS has shown small correlation to the reference standard of DLW (r= 0.28), 
43 which is similar to PASE and better than the YPAS. The CHAMPS has shown fair to good 
reliability, with intraclass correlation (ICC) coefficients ranging from 0.27 to 0.84, when measuring 
PA in people with musculoskeletal disorder and healthy older adults. 19,43-45 A more detailed review of 
reliability and responsiveness of the CHAMPS is provided in the next section of this document. 
By comparing the overall performance of the three PA questionnaires for older adults, it 
seems that the CHAMPS is an adequate choice. It combines fair to good reliability with limited 
evidence of criterion-related validity. In addition, its advantage compared to the PASE and YPAS is 
that it provides an easy way to calculate PA performed at light intensity and estimates PA in units of 
energy expenditure, allowing for direct comparison with measures from portable monitors. Thus, we 
proposed CHAMPS as the self-reported instrument to be used in our research study.  
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1.3.2.1 Reliability and Responsiveness of the CHAMPS questionnaire 
To date, six studies have investigated the test-retest reliability of the CHAMPS questionnaire. 
Measures of PA from CHAMPS have shown to be reliable after a 1-week interval (ICC= 0.78 and 
0.84), 46 after 10-days interval (ICC= 0.64 [moderate-intensity only]), 43 after a 2-weeks interval 
(ICC= 0.62 and 0.76), 19,47 and after a 6-months interval (ICC= 0.66 and 0.70) 44,48 in healthy older 
adults. Kaleth et al found fair to moderate reliability after a 2-week interval for moderate-intensity 
PA and light-to-moderate PA measures in adults with fibromyalgia, ICCs= 0.27 and 0.67, 
respectively. 47 The relatively lower reliability in Kaleth et al may be due to the higher variability in 
PA patterns in individuals with fibromyalgia in comparison to healthy older adults, as their pain 
condition may vary from one week to the other, affecting the way they perform daily activities. The 
reliability of an instrument should be measured in the population that the measure is intended to be 
used. Results from estimates of reliability derived from healthy older adults or middle-aged adult 
with fibromyalgia have limited application in older adults after TKA who may experience more 
severe physical limitations and have distinct patterns of PA. Furthermore, these studies have not 
compared the reliability of CHAMPS and portable monitor, which we propose to do in this study. 
Upon extensive literature search we identified 10 studies that used the CHAMPS 
questionnaire to estimate changes in PA in the context of intervention studies. However, only 4 
studies described data that enabled for calculation of internal responsiveness indices, 49-52 and other 
two reported these indices. 53,54 The effect sizes for CHAMPS ranged from small to moderate for 
activities performed at or above moderate intensity (0.08 and 0.68), and for light-to-moderate PA 
(0.01 to 0.66).54,55 The standardized response mean for CHAMPS were moderate for activities 
performed at or above moderate intensity (0.40 to 0.61), and ranged from small to large for light-to-
moderate PA (0.18 to 1.21).49,51-53 Although most of these studies were done in older adults, which 
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provides some evidence of the responsiveness of the CHAMPS questionnaire, none have 
determined external responsiveness of the CHAMPS or compared its responsiveness to 
accelerometer-based monitors. In addition, none of these studies have assessed reliability or 
responsiveness of CHAMPS in measuring activities of light intensity. 
1.3.3 Choice of Portable Monitors to Measure PA after TKA 
In this study, we used accelerometer-based portable monitors to measures PA objectively in subjects 
after TKA. We have selected the ActiGraphTM (ACT) and the SensewearTM armband (SWA) for 
several reasons. First, to our knowledge, the ACT and SWA are the only accelerometer-based 
monitors that have some evidence of criterion-related validity to measure PA in older adults. 43 
Second, due to their small sizes and user friendly wearing characteristics, both have shown to be well 
tolerated and add minimal burden to the subjects. Third, they both estimate PA at light and 
moderate intensity levels. Lastly, these monitors are available for me to use free of charge in this 
study. 
The ACT GT3X model, which is worn around the waist, is a small triaxial accelerometer 
(3.8cm x 3.7cm x 1.8cm in size) that measures body acceleration in the range of 0.05- 2.0 g and 
converts accelerations into activity counts. The ActiLife 5 software (Actigraph LLC, Pensacola, FL) 
allows for initializing the monitor and downloading its data, and then, it uses special equations to 
convert counts into energy expenditure measured across several intensities: sedentary (≤100 counts), 
lifestyle (101 to 759 counts), light (760 to 1952 counts), moderate (1953 to 5724 counts), and 
vigorous (5725 to 9498 counts). PA measures from the ACT have been compared to PA energy 
expenditure from DLW and demonstrated correlation coefficient of 0.49. 43 Studies validating the 
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ACT in a laboratory setting demonstrated moderate to strong correlations with energy expenditure 
measured by indirect calorimetry (correlation coefficients ranging from .55 to .85). 55-58 One of the 
limitations of the ACT, as it is worn on the waist, is its inability to capture activities that involve 
upper-extremity movement or seated activities. The ACT has shown better accuracy for ambulatory 
activity (walking and running) while it underestimates energy expenditure during work-related 
activities (e.g. desk work), certain indoor and outdoor household chores (eg, mopping, gardening), 
and some recreational tasks. 30,56,57,59-61 
The SWA Pro3 is a multi-sensor wireless monitor (8.6cm x 5.3cm x 2.0cm in size). The 
monitor is worn over the triceps muscle on the right arm, and combines information from a heat 
flux, skin temperature, galvanic signal, and biaxial accelerometer, enabling the device to estimate 
energy expenditure from activities that do not require ambulation. The heat-flux sensor measures 
the amount of heat being dissipated by the body by measuring the heat loss along a thermally 
conductive path between the skin and a vent on the side of the armband. Skin temperature and near-
armband temperature are also measured by sensitive thermal resistors. The armband also measures 
galvanic skin response (the conductivity of the wearer’s skin) which varies due to physical and 
emotional stimuli. Lastly, the accelerometers track body acceleration and position. These data are 
integrated and processed by software using proprietary algorithms utilizing the subject’s 
demographic characteristics (gender, age, height, and weight) to provide minute-by-minute estimates 
of energy expenditure during different levels of PA (from sedentary to vigorous intensity activities), 
expressed in kcal/min. PA measures from the SWA have been compared to reference standards 
such as DLW (correlation coefficients ranging from 0.48 to 0.81) 43,62 and indirect calorimetry 
(correlation coefficients ranging from 0.11 to 0.92). 55,58,63-67 
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1.3.3.1 Reliability and Responsiveness of the ACT and SWA 
Only 3 studies examined the reliability of the ACT. One study used a hydraulic shaker table to test 
the reliability of 43 ACTs in 6 different conditions, in which pairs of combinations between a variety 
of acceleration and frequency of the shaker were used. 68 This study examined inter and intra-
instrument reliability and observed excellent reliability (ICCs ≥0.95). Results from this study cannot 
be translated to our purposes because it was not done in humans who certainly vary their activities 
and acceleration patterns throughout the day. This study used tables with the same frequency of 
acceleration for all monitors, resulting in minimal variability and consequent high reliability. 
One study in healthy adults investigated the inter-instrument reliability of the ACT, 69 where 
the subjects wore two monitors at the same time, one on the right and another one on the left hip 
for 24-hr, and were instructed to engage in their normal PA habits. ICCs were all above 0.95 
indicating excellent association between monitors for PA measures (average activity counts, number 
of steps, sedentary, light, moderate and vigorous activities). The approach used in this study has 
decreased the amount of intra-individual variability as data were collected simultaneously using two 
monitors on the same subject while performing the same activities, resulting in high values of 
reliability. Calculating reliability simultaneously between two devices on the same individuals do not 
represent the clinical application intended for the use of portable monitors because usually one 
device is used to collect data in consecutive days on the same individual. Testing the test-retest 
reliability of measurements of PA taken during several days of free-living PA in a repeated-measure 
fashion reflects the clinical application of the measure.  
Another study in healthy adults investigated the test-retest reliability in free-living for a 7-day 
period with 1- to 4-week gap between each period. 70 At least 6 to 10 hours of wearing time per day 
during awaken hours for 4 days were required. The test-retest reliability was assessed by ICCs 
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between time 1 and 2 for measures of total activity counts per day, minutes spent in sedentary, light 
and moderate activities per day. Results of this study showed ICCs ranging from good (0.77 to 0.84) 
for time spent in sedentary and light intensity activities, to excellent (0.85 to 0.90) for total counts 
and time spent in moderate activities. Although the results from this study have shown that the ACT 
is reliable to measure PA over time and that subjects had fairly stable PA levels from week to week, 
this study was performed in healthy adults. Studies in healthy adults cannot be generalized to older 
adults after TKA who experience considerable physical limitations and may have patterns of PA 
very distinct than healthy adults. For example, gait abnormalities in individuals after TKA such as 
antalgic gait or asymmetric movements due to muscle weakness or joint deformities may alter the 
acceleration of their bodies and affect accelerometry measures. 71-74 
The reliability of the SWA has been investigated in four studies. Two studies were done in 
healthy adults, one in obese adults, and one is older adults. One study examined the reliability of the 
SWA during 40 min resting, with 80 min interval in between two resting occasions. 65 Subjects were 
in a reclined position and were instructed to rest and remain awake. Results of this study revealed 
excellent reliability of the device between the two resting occasions (r= 0.93). The other study in 
healthy adults assessed the test-retest reliability of the SWA while subjects participated in a pre-
established daily routine during 13-hr of standardized activities during 2 consecutive days. 75 
Activities of daily living were completed in a 3-hr period, where subjects performed 4 types of 
activities: lying awake, structured sedentary activities, spontaneous and standardized PA. Subjects 
remained seated for the remaining 10-hr. The reliability for each individual activity and the overall 
13-hr period ranged from moderate (ICC = 0.62) to excellent (ICC= 0.98). Two other studies 
examined the reliability of the SWA during periods of 20 min of resting while awake with 24 hours 
between tests. One of these studies was done in obese adults and the other in older adults. 66,76 
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Results from these studies have shown good to excellent reliability, with coefficients of reliability 
ranging from 0.88 to 0.98. While these combined studies found moderate to excellent reliability of 
the SWA between test-retest, three of them were done using resting conditions which do not reflect 
the utilization of the device during free-living conditions. The intra-individual variability during 
resting is lower than during free-living activities and would likely result in better reliability. The only 
study done during free-living conditions asked subjects to perform PA following a pre-defined 
script, in the same way it is done in a laboratory setting. The pre-defined sequence and time of PA 
result in lower variability as compared to free-living situation. Although these studies add some 
evidence to the reliability of the ACT and SWA, none of them investigated the reliability of PA 
measures at light intensity activities or compared the reliability of ACT, SWA, and self-reported 
questionnaires.  
 Our search for studies that used the ACT to assess changes in PA post interventions resulted 
in 10 studies. Amongst these, only 3 studies provided the means and standard deviation at both the 
baseline and follow-up that enabled us to calculate indices of responsiveness. A study in children’s 
weight management showed that the ACT has the ability to detect change with standardized 
response means of 0.28 for time spent in sedentary, 0.25 for time spent in light and 0.50 for time 
spent in moderate activities after a diet intervention. 77 A study in adults suffering from 3 types of 
congenital heart disease participating in a progressive walking program found effect sizes ranging 
from 0.40 to 1.21 for counts per minute, and 0.78 to 1.52 for time spent in moderate activities after 
10-week (5 days a week) intervention. 78 A study in adults with coronary disease receiving education 
and counseling reported effect sizes from 0.40 to 1.66 after 6 weeks of intervention and effect sizes 
from 1.46 to 2.61 after 12 weeks of intervention. 79 Studies assessing changes in PA post 
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interventions using the SWA were four in our literature search. 80-83 However, none of them 
provided summary statistics that could be used to calculated indices of internal responsiveness.  
 In summary, studies on the responsiveness of the ACT added some evidence to the device’s 
capability of detecting PA changes over-time in sedentary, light and moderate intensities. However, 
results of those studies have limited application to population of older adults after TKA. 
Furthermore, the responsiveness of the SWA after an exercise intervention has not been reported 
and studies have not compared the responsiveness of portable activity monitors and self-reported 
questionnaires.  
1.4 SIGNIFICANCE OF THE PROPOSED STUDY 
Literature is scarce on information about reliability, measurement error, and responsiveness of 
instruments commonly used to measure PA in research settings. Comparing reliability and 
responsiveness among portable activity monitors (SWA and ACT) and a self-report questionnaire 
(CHAMPS) during activities of light and moderate intensities performed in free-living conditions 
will allow for a well-informed choice of instruments for measuring PA in individuals with arthritis of 
the lower extremities. The results will also help to interpret data in future trials targeting PA 
promotion to increase activity participation in individuals with arthritis of the lower extremities. 
 19 
 
1.5 PRELIMINARY STUDIES  
1.5.1 Measurement Timeframe for Individuals with Arthritis to Wear Portable Monitors 
As part of my learning experience on measures of PA, I worked in a cross-sectional study to 
characterize PA and determine the measurement timeframe for wearing portable monitors to obtain 
consistent estimates of PA in women with rheumatoid arthritis. Results of this study have been 
published before.89 In this study, participants wore the SWA for 7 days. Measurements of daily 
physical activity energy expenditure (PAEE) during activities at or above 1 metabolic equivalent 
(MET) level (PAEE≥1MET), PAEE during activities at or above 2 METs (PAEE≥2METs), and 
PAEE during activities at or above 3 METs (PAEE≥3METs) were obtained. Complete data were 
obtained for 47 participants. Daily usage of the SWA was 98% of the time (23:31 hours/24 hours). 
The daily average PAEE≥1MET was 1,050 ± 331 kcal/d, for PAEE≥2METs it was 642 ± 309 
kcal/d for, and for PAEE≥3METs it was 239 ± 178 kcal/d. Results of intraclass correlation 
coefficient analyses and multiple linear regressions indicated that 4 days of data collection were 
needed to reliably estimate PAEE at the three levels.  
The above study only included women with RA who are younger then individuals after 
TKA, which questions the generalizability to the population after TKA. Therefore, we repeated the 
same protocol and analysis on 20 individuals after TKA (mean age 68 ± 7, BMI 29 ± 4) who were 
participating in another study. In this study both the ACT and SWA were used. Results indicated 
that collecting PA data in any combination of 5 consecutive days of the week allowed for consistent 
PA measures. Similar to individuals with RA, subjects after TKA spent 97.6% of the time 
performing sedentary to light intensity activities (below 3 METs). Working in these studies allowed 
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me to gain experience on processing data at several PA intensities from the portable monitors that 
were used in the proposed research study and provided support that at least full 5 days of data 
collection is needed when wearing the portable monitors to obtain consistent data. It also seems to 
support the argument that measuring PA at light intensities is relevant in this population.  
1.5.2 Experience Collecting Data Using the CHAMPS Questionnaire 
During the study mentioned above on subjects after TKA we also collected self-reported data on 
PA using the CHAMPS questionnaire. We administered the CHAMPS during the last day of wearing 
the ACT and SWA. To match the same period in which they wore the portable activity monitors, 
when answering the CHAMPS, subjects were asked to recall the last 7 days of PA. We calculated PA 
in kcal/week, according to scoring instructions, generating values of PAEE≥2METs and 
PAEE≥3METs. We then calculated the correlations between measures from the CHAMPS and 
measures from the ACT and SWA. For PAEE≥2METs, the correlation between the CHAMPS and 
SWA was r = 0.56. In this study, we did not have data on PAEE≥2METs from the ACT because 
we used an older version of the ACT software (ActiLife v.4). For the proposed study, the ActiLife 
v.5 was used, which allowed determination of PAEE≥2METs. For PAEE≥3METs the correlation 
between the CHAMPS and ACT was r=-0.04, and between CHAMPS and SWA the correlation was 
r = 0.51. This pilot work supports my experience using the CHAMPS questionnaire in subjects after 
TKA. 
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1.5.3 Validity of Physical Activity Measures in Individuals after TKA in a Laboratory 
Setting 
I worked in a study that investigated the validity of ACT and SWA to measure PA in a laboratory 
setting in 21 subjects after TKA (mean age 68 ± 7, BMI 29 ± 4). Results of this study have been 
published before.84 PA was concurrently measured by the two portable monitors and the reference 
standard of indirect calorimetry (VO2000, Medical Graphics Corporation, St. Paul, MN). Subjects 
performed several activities during 6 minutes each. The list of activities is depicted in Figure 1. 
Results indicated that the accuracy of the ACT was lower than the accuracy for the SWA. The SWA 
showed good accuracy for all activities tested in the study, from lying down to fast walking speed 
(Figure 1 and 2).  
By working in this study I acquired skills at operating the indirect calorimeter and analyzing 
its measures, and gained experience on the complexities of data processing and management. The 
study that we are proposing is the next step to investigate the reliability and responsiveness of PA 
measures during free-living condition after TKA.  
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(§) p ≤ 0.05 between energy expenditure in kcal/min measured by the ACT and the VO2000; (ǁ) p 
≤ 0.05 between energy expenditure in kcal/min measured by the SWA and the VO2000. 
Figure 1. Graph representing energy expenditure measured by the Actigraph (ACT), the SenseWear 
Armband (SWA), and the reference standard (VO2000) across non-walking activities.  
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(§) p ≤ 0.05 between energy expenditure in kcal/min measured by the ACT and the VO2000; (ǁ) p 
≤ 0.05 between energy expenditure in kcal/min measured by the SWA and the VO2000. 
Figure 2. Graph representing energy expenditure measured by the Actigraph (ACT), the SenseWear 
Armband (SWA), and the reference standard (VO2000) across walking speeds.  
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1.6 OBJECTIVES/SPECIFIC AIMS/RESEARCH QUESTIONS 
The purpose of this research study was to determine the reliability and responsiveness of measures 
of PA at light and moderate intensities taken by the ACT, the SWA, and the CHAMPS, and to 
compare the psychometric properties across these measurement tools in subjects after TKA. 
1.6.1 Specific Aim 1  
To determine the reliability and measurement error of measures of PA at light and moderate 
intensities estimated by the ACT, SWA and CHAMPS, in subjects after TKA.  
1.6.1.1 Hypothesis 1 
Measures of PA taken during two consecutive weeks will show good test-retest reliability for the 
three instruments, with intra-class correlation coefficients above 0.70 for activities of both light and 
moderate intensities. Measurement error will be determined by calculating the standard error of 
measure for the three measurement tools. 
For this aim, PA was measured by the ACT, SWA, and the CHAMPS during two 
subsequent weeks in the subjects who report stable levels of PA. Measures of PA from week one 
were compared to measures of PA from week two.  
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1.6.2 Specific Aim 2 
To determine the responsiveness of measures of PA taken at light and moderate intensities 
estimated by the ACT, SWA and CHAMPS in individuals after TKA undergoing an exercise 
program. 
1.6.2.1 Hypothesis 2a 
Measures of PA taken by the ACT, SWA and CHAMPS will be able to identify changes in PA 
performed at light and moderate intensities from pre to post-intervention.  
1.6.2.2 Hypothesis 2b 
The SWA will be more sensitive to detect changes in PA than the ACT, and the ACT will be more 
sensitive to detect changes in PA than the CHAMPS. 
1.6.3 Specific Aim 3 
To explore the associations between a modified global rating of change, which measures an 
individual’s perceived changes in PA, and PA at light and moderate intensities estimated by the 
ACT, SWA and CHAMPS in individuals after TKA undergoing an exercise program. 
1.6.3.1 Hypothesis 3 
Changes in PA measured by the modified global rating of change will be associated with 
changes in PA measured by the ACT, SWA and CHAMPS (correlation coefficients of at least 
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moderate magnitude), which will support the use of the global rating of change as an external anchor 
to determine thresholds of clinical important changes in measures of PA. 
For aims 2 and 3, PA will be measured by the ACT, SWA, and the CHAMPS before 
(baseline) and after subjects undergo an exercise program (6 months). The global rating of change 
scale will be completed only at the end of the exercise program. Changes in PA at light and 
moderate intensities estimated by the ACT, SWA and CHAMPS were compared with scores on the 
global rating of change.   
1.7 RESEARCH DESIGN 
1.7.1 Study Overview  
This is an ancillary study from a randomized trial that investigates the effect of rehabilitation 
approaches to improve quality of life in individuals following TKA. The proposed study used data 
from the baseline and follow-up assessments of all subjects in the parent trial to determine the 
reliability and responsiveness of measures of PA assessed by the ACT, the SWA, and the CHAMPS, 
and compare the psychometric properties across these measurement tools. Eligible subjects 
performed baseline measures of outcome, and then were randomly assigned to a Comprehensive 
Behavioral Intervention (CBI) or Standard Physical Exercise program (SPE). Follow-up assessments 
were performed 6 months after randomization. Since the effectiveness of interventions is not the 
aim of the proposed study, the data from the two intervention groups were combined for the data 
analysis.  
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For this ancillary study, reliability and measurement error were determined at the baseline. 
During baseline testing, subjects wore the ACT and the SWA for two consecutive weeks, and 
completed the CHAMPS at the end of each week. Subjects were asked to perform similar physical 
activities during the two weeks of measurement. Stability of PA was measured by asking the subjects 
if they performed more, less or about the same activities in week 2 comparing to week 1. Then, data 
for subjects with stable patterns of PA (about the same activities) were used to determine reliability.  
To determine responsiveness, PA measured by the ACT, SWA, and the CHAMPS before 
(baseline) and after (6-months) subjects underwent the interventions being tested in the parent study 
was used. The global rating of change in PA was collected at the 6-month timeframe. Changes in PA 
at light and moderate intensities estimated by the ACT, SWA and CHAMPS were compared with 
scores on the global rating of change.   
All evaluations and interventions were held in the Physical Therapy Clinical and 
Translational Research Center (PT-CTRC) at the University of Pittsburgh.  
1.7.2 Study Sample 
Subjects following a unilateral TKA were recruited from the Orthopedic Program at Magee 
Women’s Hospital at UPMC from a single surgeon. Since this study used subjects after TKA who 
were participating in a randomized trial, the inclusion-exclusion criteria were similar to the parent 
study.  
Inclusion Criteria – Subjects were asked to participate in the study if they: (1) Underwent 
unilateral TKA at least three months prior to, but no longer than six months prior to study 
participation. Three months after the surgery is needed to surpass the sub-acute recovery period 
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when pain, effusion, and knee motion are clinically improved and no longer restrict more intense 
exercises; (2) The surgical technique was a minimally invasive (quadriceps sparing) TKA performed 
by the same experienced surgeon. This was to avoid variability in surgical technique and surgeon’s 
practice; (3) Provided a written medical clearance to participate in the study; (4) Spoke fluent 
English- necessary to reliably complete the study questionnaires and understand study instructions; 
(5) Were 50 years and older; (6) Were willing to be randomized to either treatment group. Additional 
inclusion criteria specific to this ancillary study included: (7) Willingness to wear the portable 
monitors for 2 weeks during baseline period, and answer the CHAMPS twice; (8) Commitment to 
perform similar activities during the 2 baseline weeks of data collection. All subjects from the main 
RCT were invited to participate in this ancillary study.  
 Exclusion Criteria – Participants were excluded from the study if they: (1) Have had bilateral 
or TKA revision; (2) Have had hip or ankle joint replacement; (3) Were unable to comfortably bear 
weight on the surgical knee; (4) Have had 2 or more falls within past year; (5) Had an uncontrolled 
medical condition that would prevent safe participation in the study (uncontrolled blood pressure, 
dyspnea at rest, cardiovascular disease, absolute contraindications to exercise, 36 and diabetes); (6) 
Participating in regular exercise during prior 6 months; (7) Use of beta blockers, (8) Have a 
neurological condition that affects locomotion; (9) Have had a malignancy, life-threatening illness or 
surgery in the past six months; and (10) Have had a TKA done using a technique other than the 
minimally invasive. 
1.7.3 Outcome Measures 
Physical activity was measured by the ACT, the SWA, and CHAMPS.  
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The ACT (GT3X model) is a small triaxial accelerometer (2 x 1.5 x 0.6 inches in size) worn 
around the waist, on the hip bone aligned with the anterior superior iliac spine. To initialize the 
monitor and download its data, the ActiLife 5 software (Actigraph LLC, Pensacola, FL) was used. 
The software generates activity counts by default and was set to collect data at 1 min intervals. 
Activity counts/min were converted into kilocalories per min (kcal/min) using the ACT software 
ActiLife 5. The ACT was worn during 2 weeks at baseline and during 1 week at the 6-month follow-
up. Its battery lasts for up to 20 days. The ACT has demonstrated adequate validity as a tool to 
measure PA in free-living conditions in young healthy adults. 85,86,87,43,88 
The SWA (Pro3 model) is a monitor worn on the back of the right arm (midpoint between 
shoulder and elbow). The SWA combines information from multi-sensors such as biaxial 
accelerometer, heat flux (heat being dissipated by the body), galvanic signal (onset, peak and 
recovery of maximal sweat rates) and skin temperature. The information is integrated and processed 
by the SenseWear Professional software v6.1 (BodyMedia Inc., Pittsburgh, PA) using proprietary 
algorithms utilizing subjects’ demographic characteristics (gender, age, height, and weight) to provide 
PA data measured in kcal/min. SWA has a battery life of 14 days. The SWA was worn during two 
weeks at baseline and during 1 week at the 6-month follow-up. The SWA has shown adequate 
validity for assessing PA in free-living conditions in obese and healthy adults. 43,62,89,90 
The software used to download data from the ACT and the SWA allow researchers to 
calculate energy cost at any metabolic equivalent (MET) level. Therefore, daily averages of PA 
energy expenditure (PAEE) at 3 different intensity levels were calculated: (a) PAEE during activities 
at or above 2 METs (PAEE≥2METs), (b) PAEE during activities between 2 and 3 METs 
(PAEE=2-3METs), and (c) PAEE during activities at or above 3 METs (PAEE≥3METs). Figure 3 
exemplifies the measures of PA at different intensities. As at rest the average person has an oxygen 
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consumption of 3.5 ml/kg/min (or 1 MET). The measure of PAEE≥2METs represents the daily 
energy spent at or above light activities such as slow walking (±2mph), light cycling (±5 mph), 
playing a musical instrument, bartending, cooking, scrubbing, and showering. Finally, the measure of 
PAEE≥3METs represents the daily energy spent at or above moderate activities such as crisp 
walking (≈3 mph), cycling (≈5.5 mph), bowling, canoeing, janitorial work, cleaning windows, and 
climbing stairs. An additional variable processed by the ACT and SWA is total energy expenditure 
(TEE). Total EE represents energy spent at any MET level, from sleeping peacefully to vigorous 
PA, which includes all values of PAEE. 
The CHAMPS is a 41-item self-administered questionnaire with a list of specific activities 
varying from light to vigorous intensity, to which subjects report their frequency and approximate 
duration of participation in activities in the last week. The questionnaire assesses frequency in times 
per week, and classifies duration according to time spent in each activity, ranging from <1hr/week 
to 9 or more hr/week. The information is used to quantify EE (kcal/week). Values are calculated to 
quantify PA in kcal/week, according to original scoring instructions, generating values of 
PAEE≥2METs and PAEE≥3METs.44   The CHAMPS was completed at the end of each of the two 
baseline weeks of PA data collection, and at the end of the 6-month, after the week the activity 
monitors were worn. The CHAMPS has shown reasonable validity to measure PA in older adults 
19,21,44 
Stability of PA measures: Subjects who agree to participate in the reliability portion of this 
study were asked to compare the activities that they performed during the 2nd week to the 1st week 
of wearing the monitors. They had the options to answer if they were more active, less active, or 
about the same.  
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Global Rating of Change in PA: Subjects completed a modified global rating of change 
regarding change in PA status from the time they entered the study to the follow-up assessment. 
Subjects rated how they perceived the overall change in PA since the beginning of intervention using 
a 15-point rating scale described by Jaeschke et al.91 The global rating of change ranges from -7 (“a 
very great deal less PA”) to 0 (“about the same”) to +7 (“a very great deal more PA”). Intermittent 
descriptors of less or more are assigned values from -1 to -7 and from +1 to +7, respectively. 
Additional Measures: Demographics, self-reported physical function (measured by the 
Western Ontario and McMaster Universities Osteoarthritis Index), quality of life (measured by the 
SF-36), BMI, and blood pressure, were collected from the parent trial and were used to characterize 
the sample. 
1.7.4 Interventions Investigated in Parent Trial 
Subjects were masked from the detailed content of the interventions or study purposes (some 
general information were provided according to IRB requirements). The exercise interventions were 
delivered by a physical therapist (GJA) and last for 6 months. Both interventions were designed to 
improve aerobic capacity and muscle strengthening. It was expected that the SPE group would 
demonstrate small increase whereas the CBI group would demonstrate moderate increase in PA. 
Therefore, across subjects in both groups, we expected a large variability in changes in measures of 
PA, providing a good sample to test the responsiveness of these measures. The interventions’ plan is 
represented in Figure 4. 
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1.7.4.1 Control Group - Standard Physical Exercise Program (SPE) 
The SPE represents the typical rehabilitation after TKA surgery. It was expected to provide small 
improvement in function and PA.92 Subjects participated in 12 supervised sessions delivered during 
12 weeks, followed by a home exercise program performed 2x/week at the same intensity as done 
under supervision up to 6 months. The SPE consists of: (a) lower extremity range of motion and 
stretching exercises, (b) lower extremity strengthening exercises, and (c) endurance exercises using 
treadmill or stationary bicycle. We followed the ACSM guidelines for older adults for dosing and 
progression of exercises.93 Strengthening exercises were progressed from light to moderate loading 
(40% to 60% of 1 repetition maximum). To assess intensity, for each exercise, we started by adding a 
light but reasonable load and asked the subject to perform 30 repetitions, which corresponds to 40-
50% of maximum strength. Additionally, we asked the subject to grade his/her effort according to a 
10-point exertion scale, which must have fallen between 3 to 4, representing light-intensity. 93 
Progression to a moderate intensity was made by adding more load and decreasing the repetitions up 
to 15, with an effort perception not more than 6 points, representing moderate intensity. For the 
endurance training performed on the treadmill or stationary bicycle, the subject was required to 
maintain his/her heart rate between 50% and 60% of the predicted value (220 - age), representing 
light to moderate intensity. 
1.7.4.2 Experimental Group - Comprehensive Behavioral Intervention (CBI) 
The CBI consisted of regular contacts over 6 month period. It included 2 weekly contacts for weeks 
1-6, weekly contacts for weeks 7-8, biweekly contact from months 3 to 4, and once a month from 
months 5 to 6. There was a combination of 12 supervised exercise sessions, 7 self-management and 
one nutrition-guidance session, for a total of 20 sessions. The CBI was composed of 4 components:  
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a. The evidence-based exercise program was based on published research after TKA.94-96 It 
combined (a) lower extremity strengthening exercises; (b) endurance exercise on the treadmill; (c) 
functional task-oriented exercises with exercises such as chair rises and stair climbing; (d) balance 
techniques such side stepping, forward and backward tandem walking, and single-leg-standing 
balance. During the 12 supervised exercise sessions (delivered during 12 weeks), subjects were 
instructed to become independent in performing the exercises at home.  We followed the ACSM 
guidelines for older adults for dosing and progression of exercises.93  Strengthening exercises were 
progressed from moderate to high loading (60% to 80% of one repetition maximum). To assess 
intensity, for each exercise, we started by adding a moderate load and asked the subject to perform 
17 repetitions at maximum fatigue, which corresponded to 60% of maximum strength. Additionally, 
we asked the subject to grade his/her effort according to a 10-point exertion scale, which must have 
fallen between 5 to 6, representing moderate intensity. 93 Progression to a vigorous intensity was 
made by using stronger elastic bands and decreasing the number of repetitions up to 8 to maximum 
fatigue. Reported exertion score was not greater than 8 points, representing vigorous intensity. For 
the endurance training performed on the treadmill or stationary bicycle, the subject was encouraged 
to exercise at moderate intensity. Recent studies demonstrated that the effects of cardiorespiratory 
fitness are comparable between moderate and high intensities. 97,98 Subjects were required to 
maintain their heart rate between 55% and 70% of the predicted value (220 - age), representing 
moderate intensity.  To avoid excessive stresses over the prosthesis, subjects were limited to walk up 
to 4.5 mph. Exercise behavior were monitored by diaries. 
b. Physical activity promotion was based on the program that has been previously developed and 
tested in overweight and sedentary women. 99,100 Subjects were instructed to engage in moderate or 
higher intensity exercise for 5 days a week.  They began at 20 min or less of walking per day, and 
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gradually progressed to 60 min per day, as recommended by leading organizations. 101,102   Progression 
was gradual (5-10 min/d in 4 week intervals) to maximize adherence and minimize musculoskeletal 
injury. Physical activity instructions were delivered by physical therapist along with the 12 sessions of 
supervised exercise program. Physical activity was monitored daily by the SWA, and downloaded 
into the Professional Software. Subjects wore a wrist watch that synchronized with the SWA and 
provided real-time feedback of minutes of PA, allowing them to alter their PA behaviors to achieve 
the intervention goals.  
c. Healthy nutrition guidance: Subjects received instructions on healthy nutrition based on the 
Dietary Guidelines for Americans. Only obese subjects were prescribed an energy restricted diet that 
has demonstrated to be effective in reducing weight. 100,103 For subjects attempting to lose weight, 
dietary intake was monitored using food diaries. Overweight (not obese) individuals were not 
offered a restricted diet since in older adults some extra weight may be beneficial. 104 This 
intervention was delivered by a registered dietitian in small group sessions (one session for all 
subjects and an additional session for the obese subjects). Body weight was frequently measured at 
each session and subjects were encouraged to measure it on their own.  
d. Self-management integrated the basic self-management skills advocated by the Arthritis 
Foundation Self-Help Program and behavioral strategies such as self-monitoring, problem solving, 
relapse prevention, and goal-setting and feedback  into approaches a, b and c from above. 105,106 
Subjects were provided educational written materials to supplement the individual or group sessions 
and to develop the behavioral skills necessary for appropriate exercises, sufficient physical activity, 
and adequate nutrition. Discussion was facilitated by the interventionist. Monitoring was also an 
important part of self-management. Exercises, PA data, and body weight were regularly reviewed by 
the research staff and information was used to provide feedback of accomplishments, generate 
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discussion to revise goals, and discuss problem solving strategies related to the CBI. Seven sessions 
were devoted to self-management intervention.  
 
Figure 3. Schematic representation of daily values of energy expenditure. 
1.8 ANALYSIS PLAN 
Descriptive statistics including means, 95% confidence intervals (CI) and standard deviations, 
median and 25-75 percentiles, and counts and frequencies were used according to the type and 
distribution of data. Summaries were provided for subjects’ characteristics and measures of PA at 
baseline (week 1 and week 2) and 6-month follow-up.  
1.8.1 Hypothesis 1 
Test-retest reliability of PA measures taken during 2 consecutive weeks will show good consistency for the three 
instruments, with intraclass correlation (ICC) coefficients above 0.70. Data from subjects who agreed to 
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perform similar activities for two consecutive weeks will be used in the reliability analysis. Test-retest 
reliability of PA measured by the SWA, ACT and CHAMPS will be determined by ICC. The model 
ICC2,k will be used, where ‘2’ reflects the test-retest and ‘k’ the average of all days containing PA 
data. ICCs will be determined using the absolute agreement definition for variables generated by the 
ACT and SWA (PAEE≥2METs, PAEE=2-3METs, PAEE≥3METs and number of steps), and 
CHAMPS questionnaire (PAEE≥2METs and PAEE≥3METs). The 95% confidence intervals 
around the ICC values will be calculated. We will also use Bland and Altman plots to compare the 
mean difference between two methods of measurement, and to compute the 95% limits of 
agreement to allow assessment of systematic difference between the measurements and to identify 
possible outliers. Measurement error will be calculated as the standard error of measurement (SEM), 
which is based on the reliability coefficient (ICC) and variance (SD) of measures from week 1 and 
week 2 from each PA measurement tool using the equation: SEM = SD √1-ICC. We will also use 
the SEM to derive the minimum detectable change (MDC) for each PA measurement tool. The 
MDC is calculated as the amount of change needed to be certain, within a defined level of statistical 
confidence that change is beyond measurement error. 107 The equation ‘MDC = z score level of 
confidence x √2 x SEM’ was used. 108 MDCs were calculated using the standard normal scores of 
1.96 (associated with 95% CI - MDC95) and 1.65 (associated with 90% CI - MDC90). 
1.8.2 Hypothesis 2a  
Measures of PA by the ACT, SWA and CHAMPS will identify significant increase in moderate and light intensity 
PA from pre to post-intervention (6 months). Significance of changes in PA measured by the ACT, SWA 
and CHAMPS from pre to post intervention will be calculated using paired t-test. We will perform 
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the same approach for light and moderate levels of PA. All hypothesis testing will be tested at 
α=0.05. 
1.8.3 Hypothesis 2b  
The SWA will be more sensitive to changes in measures of PA than the ACT, and the ACT will be more sensitive 
to detect changes in measures of PA than the CHAMPS. To test this hypothesis, we will perform two 
analyses. First, we will use paired t-test to compare the change-scores at 6-month follow-up between 
each pair of PA measures. (ACT vs. SWA, ACT vs. CHAMPS, and SWA vs. CHAMPS). The same 
approach will be performed for light and moderate levels of PA. Graphs will be plotted to compare 
slopes of lines from pre to post intervention for all PA levels measured by each instrument. Second, 
we will calculate the standardized response mean (SRM) and Guyatt responsiveness index (GRI) to 
identify which PA measurement tool was more responsive to change after an exercise intervention. 
The SRM is the ratio of mean change to the standard deviation of the change scores,108 and the GRI 
is the ratio of mean change divided by the standard deviation of change in subjects who remained 
unchanged or worsened.7 
1.8.4 Hypothesis 3 
Changes in PA measured by the modified global rating of change will be associated with changes in PA measured by 
the ACT, SWA and CHAMPS (correlation coefficients of at least moderate magnitude), which will support the use 
of the global rating of change as an external anchor to determine thresholds of clinically important changes in measures 
of PA. Correlations between the modified global rating of change and changes in PA measured by 
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the ACT, SWA and CHAMPS, will be calculated using Pearson or Spearman correlation coefficient 
(depending on data distribution). If the association between global rating scores and changes in 
measures of PA are of at least moderate magnitude, we will attempt to derive cut-offs of clinically 
important improvement using the method of the area under the receiver operating characteristic 
(ROC) curve. 14 If associations between global rating scores and changes in measures of PA are 
below moderate magnitude it will indicate that the modified global rating of change scale may not be 
appropriate as an external anchor for external responsiveness of PA measures.  
1.8.5 Sample Size Estimation 
We proposed to recruit 50 subjects to allow for 40 subjects at 6 months (assuming 20% attrition at 6 
months). With 40 subjects, α = 0.05, we will have 87% power to detect an ICC= 0.75 in the test-
retest reliability, with a lower bound of 95%CI as low as 0.40 for all instruments. For the paired t-
test, 10 subjects per group were required to detect a small improvement in PA from pre to post 
intervention. Sample size of 40 would allow above 100% power to identify significant difference in 
the paired t-test to test the significance of change of each instrument from pre to post, and also to 
compare the significance of changes among the instruments. 
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Figure 4. Representation of study flow with the distribution of interventions through 6 months. 
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2.0 CHAPTER 2 - RELIABILITY OF PHYSICAL ACTIVITY MEASURES DURING 
FREE-LIVING IN INDIVIDUALS AFTER TOTAL KNEE ARTHROPLASTY 
2.1 SUMMARY 
Background: Few instruments that measure physical activity (PA) can accurately quantify PA 
performed at light and moderate intensities, which is particularly relevant in older adults. However, 
the evidence of their reliability in free-living condition is limited. Objectives: To determine test-
retest reliability of the Actigraph (ACT), SenseWear Armband (SWA) and the Community Healthy 
Activities Model Program for Seniors (CHAMPS) questionnaire in assessing free-living PA at light- 
and moderate-intensities in individuals following total knee arthroplasty (TKA), and compare their 
reliability in commonly used monitoring timeframes (‘24-hours’, ‘wake-hours’, and ‘10-hours from 
awakening’). Design: One-group, repeated-measures. Methods: Subjects wore the activity monitors 
for two weeks. At the end of each week data were downloaded and the CHAMPS was completed. 
Measures from week one were compared to those of week two. Results: Twenty-eight subjects 
reported similar PA during the two weeks and were included in the analysis. Mean age was 69(8) 
years and 75% were female. Test-retest reliability determined by intra-class correlation coefficient 
(ICC) ranged from moderate to excellent for the ACT (ICC=0.75-0.86), and excellent for the SWA 
(ICC=0.93-0.95) and CHAMPS (ICC=0.86-0.92). The 95% confidence intervals of the ICCs from 
SWA were the only ones within the range of excellent reliability (0.85-0.98). The CHAMPS 
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demonstrated systematic bias with less PA reported in week two. Reliability of PA measures in 
‘wake-hours’ timeframe was comparable to ‘24-hours’ and reflected most PA performed during this 
period. Limitations: Reliability may be lower for time-intervals longer than one week. 
Conclusions: All PA measures had good reliability. Reliability of the ACT was lower than the SWA 
and CHAMPS. The SWA provided better precision of reliability estimates. Wearing PA monitors 
during wake-hours provided reliable measures and can reduce subjects’ burden. 
2.2 INTRODUCTION 
Regular physical activity (PA) contributes to health enhancement in many ways. It helps maintain 
weight, prevents chronic diseases such as diabetes, depression and hypertension, and reduces 
mortality.109 Individuals who undergo total knee arthroplasty (TKA) for end-stage knee osteoarthritis 
are typically older adults who have an inactive lifestyle and perform most of their activities at light 
intensities due to persistent knee pain and functional limitations. 110-112 Thus, measuring PA using 
reliable measurement tools able to capture light intensity activities is warranted.  
Several instruments are available to measure free-living PA in older adults, which is defined 
as daily activities performed by the individuals at their own pace under no supervised or controlled 
conditions.113,114 But only a few instruments are able to accurately distinguish light (e.g., mopping and 
walking to do errands) from moderate (e.g., lawn mowing and brisk walking) intensities of PA.19,48,115-
118 Among those instruments, two accelerometer-based activity monitors, the Actigraph (ACT; 
Actigraph LLC, Pensacola, FL) and the Sensewear Armband (SWA; Bodymedia, Pittsburgh, PA), 
and a self-reported questionnaire, the Community Health Activities Model Program for Seniors 
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(CHAMPS), have been validated to measure PA in older adults and are widely used in research that 
include this population.43,44,84 The ACT is a waist-mounted accelerometer-based device and the SWA 
is an arm-mounted multi-sensor device. Their advantage is to measure PA in real time as compared 
to CHAMPS that relies on individuals’ recall. Although the costs of activity monitors are substantial 
compared to questionnaires, their cost is reasonable for large-scale research. Also, they are far less 
expensive than doubly labeled water that is the reference standard to measure PA in free-living. A 
drawback of activity monitors is that they need to be worn for several hours per day and several days 
a week to capture relevant PA information. The advantages of the CHAMPS include information 
about the type of PA behaviors (e.g., dance, walk to do errands), very low cost, and it is easy to 
administer with minimal subjects’ burden (15 minutes to complete). Yet, PA questionnaires have 
been found to overestimate moderate PA and underestimate sedentary behavior.48,119  
To date, there is limited information on the reliability of these instruments to measure PA in 
older adults with arthritis of the lower extremities. To our knowledge, no studies have determined 
the reliability of the SWA in free-living conditions. Studies that used the ACT and CHAMPS to 
measure free-living PA were mainly in healthy individuals.19,44,46,48,70,120 Results from healthy 
individuals may not be applicable to those with knee osteoarthritis who usually have pain and 
functional limitations, which may lead to gait abnormalities, inactive lifestyle, and obesity.1,121 More 
importantly, studies have not compared the performance of the ACT, SWA and CHAMPS. 
Therefore, it is key to concurrently compare the reliability between measures of PA from activity 
monitors that use distinct technologies and a self-report questionnaire. This comparison will provide 
evidence for researchers and clinicians for a well-informed choice of tools to assess PA in 
individuals with arthritis of the lower extremity.  
 43 
 
Specific to accelerometry-based devices, evidence is also limited in terms of the appropriate 
timeframe to wear the monitors. Most of the studies that investigated the consistency of measures of 
PA in different monitoring timeframes have done so in terms of number of days, but few on the 
amount of hours per day.114,122,123,124 The most commonly used monitoring timeframes in research to 
assess free-living PA have been 10-hours, wake-hours, and 24-hours.114,122,123,124 To investigate which 
monitoring timeframe provides more reliable estimates of PA may help reduce subjects’ burden if 
shorter monitoring periods yield consistent PA measures.  
The main purpose of this study was to determine the test-retest reliability of the ACT, SWA, 
and CHAMPS to assess participation in free-living PA at light- and moderate-intensities in 
individuals with knee osteoarthritis who underwent TKA. We also aimed to compare the reliability 
across the three instruments. Additionally, we aimed to determine test-retest reliability of monitoring 
timeframes that are commonly used to assess PA when using the ACT and SWA.  
2.3 METHODS  
2.3.1 Design and Subjects 
This is an ancillary study that used a one group, repeated-measures design. Subjects participating in a 
randomized trial that investigated the effect of rehabilitation approaches to improve quality of life in 
individuals following TKA were invited during baseline assessment to take part in this reliability 
study. This study took place from October 2011 to March 2013 in the Department of Physical 
Therapy, University of Pittsburgh. All subjects signed a consent form approved by the University of 
Pittsburgh Institutional Review Board prior to participation. 
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In the parent study, individuals were included if they had a unilateral TKA in the past 3-6 
months and were at least 50 years old. To be included in this ancillary study, individuals also had to 
be willing to wear the activity monitors for two consecutive weeks, to complete the CHAMPS twice, 
and to agree to perform similar activities during the two weeks of data collection. For safety reasons, 
individuals were excluded from the parent study if they reported more than two falls within the past 
year, were unable to ambulate a distance of 31 meters without an assistive device, and had medical 
conditions that precluded safe exercise participation.  
2.3.2 Study Protocol 
Subjects attended three testing visits. In the first testing visit they completed demographic, pain and 
physical function self-reported questionnaires, and had their height and weight measured. Knee pain 
was assessed by a numeric pain scale that ranges from 0 (no pain) to 10 (worse imaginable pain). 
Physical function was measured using the Western Ontario and McMaster Universities 
Osteoarthritis Index-Physical Function (WOMAC-PF). The WOMAC-PF is a self-report 
questionnaire that includes 17 items, each scored from 0 (no limitation) to 4 (extreme limitation), 
with a total score of up to 68 points. Higher scores indicate worse function. The WOMAC-PF has 
shown adequate test-retest reliability (associations ranged from 0.68 to 0.92) 125 and validity when 
compared to measures of patient satisfaction, and health-related quality-of-life such as the SF-36 
(associations ranged from 0.48 to 0.64) 125 in people with knee and/or hip osteoarthritis.  
At the end of the first visit, subjects were fitted with the ACT and SWA and were instructed 
to wear the monitors for 7 days (24 hours a day), except during water activities since the activity 
monitors are not waterproof. Subjects were asked to perform similar activities during the two weeks 
 45 
 
of data collection. At the end of week one (test) and week two (retest), subjects returned to 
download the data from the activity monitors and to complete the CHAMPS (Figure 5). The 
CHAMPS questionnaire queries PA participation in the past week, which corresponds to the time 
they wore the monitors. Data from the activity monitors were inspected to assure sufficient data, 
which was defined as at least 5 days with 10-hour of PA data per day. 122,126,127 Subjects without 
sufficient data were asked to wear the portable monitors for an additional week and to complete the 
CHAMPS at the end of that week. To assess stability of PA during the two weeks of data collection 
subjects were asked to compare their PA participation between the two weeks by answering if they 
performed more, less, or about the same activities during that period. Data from subjects who 
reported about the same activities during two weeks, and had at least 5 days with 10-hour data for 
the ACT and SWA were used in the reliability analysis. 
 
 
 
Figure 5. Flow chart of the test-retest reliability protocol. 
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2.3.3 Measures of Physical Activity 
The main outcome of this study was duration and caloric expenditure of daily PA estimated by the 
ACT, SWA and CHAMPS. We also assessed daily number of steps using the ACT and SWA. The 
PA measurement tools in use in this study have distinct measurement characteristics to differentiate 
the intensity levels of PA into light (e.g., recreational activities, slow walk), moderate (e.g., 
vacuuming, brisk walk), and vigorous (e.g., lawn mowing, doubles tennis). The measures of 
moderate and vigorous-intensity activities were combined into the moderate category since our 
sample engaged in negligible amounts of vigorous-intensity activities. The intensity categories of PA 
compared across the three instruments in this study were light, moderate, and light-to-moderate 
(combination of light and moderate intensities).  
2.3.3.1 Actigraph 
The ACT is a small triaxial accelerometer-based monitor (2 x 1.5 x 0.6 inches in size) worn around 
the waist, at the level of the hip-bone, over the right anterior superior iliac spine. In this study we 
used the ACT model GT3X and the ActiLife 5 software (Actigraph LLC, Pensacola, FL). The ACT 
measures body acceleration in activity counts, and was set to collect data at 1-minute intervals. The 
ACT generates data on activity counts per minute (CPM) and number of steps. To categorize 
duration of daily activities in minute per day (min/day), the software uses the following CPM cut-
points: 760-1951 CPM for light, CPM >1951 for moderate, and ≥760 CPM for light-to-moderate 
intensities. 128 
The ACT also uses body weight to generate measures of caloric expenditure in kilocalories 
per day (kcal/day). Freedson equation is used to calculate kcal/day for moderate intensity activities 
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whereas the Combination equation is used to calculate kcal/day for light-to-moderate intensity PA. 
128  To generate values for light intensity activities, we subtracted the values of Freedson equation 
from Combination equation as recommended by the manufacturer. The ActiLife 5 software 
identifies non-wear periods using a threshold of 60 consecutive minutes with zero CPM that 
indicates no movement at all, and allows for up to two minutes of 1-100 CPM in between the 60 
minutes. Non-wear periods were also visually analyzed. Measures of PA in free-living from the ACT 
have demonstrated moderate accuracy (r= 0.49) with doubly labeled water in older adults, 43 and 
moderate to excellent reliability to assess PA in free-living in healthy adults (ICC= 0.68 to 0.90). 70,120 
2.3.3.2 SenseWear Armband 
The SWA is a small multi-sensor device (3.4 x 2.1 x 0.8 inches in size) worn on the back of the right 
arm, over the triceps muscle, at midpoint between shoulder and elbow. We used the SWA model 
Pro-3 and the Professional software v6.1 (BodyMedia Inc., Pittsburgh, PA). The SWA combines 
information from biaxial accelerometer, heat flux (heat being dissipated by the body), galvanic signal 
(onset, peak and recovery of maximal sweat rates) and skin temperature. The information from the 
sensors is integrated and processed by the software using proprietary algorithms that account for 
subjects’ demographic characteristics (gender, age, height and weight).  
The SWA was set to provide data on number of steps, duration of activities (min/day), and 
caloric expenditure (kcal/day) in light (2 to 2.9 metabolic equivalents [METs]), moderate (≥3 
METs), and light-to-moderate intensities (≥2 METs). The SWA turns off automatically when not in 
contact with the skin which enables the software to recognize periods of non-wear. Data were also 
visually screened to identify non-wear periods. The SWA has shown moderate accuracy (r= 0.48) in 
comparison to doubly labeled water in older adults. 43 
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2.3.3.3 Community Health Activities Model Program for Seniors  
CHAMPS is a self-reported questionnaire that queries type, frequency and duration of 41 activities 
usually performed by older adults, ranging from light to vigorous intensities, such as cleaning, 
gardening and sports activities. Duration in hours per week (hr/week) of each activity is selected 
from a range of less than one hour per week to 9 or more hours per week, and categorized in two 
intensity levels according to the CHAMPS activities codebook. 44 Light-to-moderate intensities (≥2 
METs) represent all exercise-related activities queried by the questionnaire, such as light to heavy 
household chores, and recreational and sports activities. Moderate intensity activities (≥3 METs) 
represent activities such as heavy household chores, calisthenics and sports. To allow direct 
comparison between CHAMPS and the accelerometer-based monitors, the moderate category was 
subtracted from light-to-moderate to create a light intensity category for the CHAMPS. 
The caloric expenditure from CHAMPS is provided in kcal/week using equations that weigh 
the intensity of each activity according to the energy requirements for older adults, and also accounts 
for subjects’ body weight. Kcal/week is calculated using the type, frequency, and duration of each 
activity reported.44 Scores from the CHAMPS in hr/week or kcal/week were converted into 
min/day and kcal/day respectively by multiplying the duration score by 60 minutes and then 
dividing by 7 days. Data on water activities described by the CHAMPS (i.e., items 31 to 33) were 
excluded from the calculation of PA scores since subjects were required to remove the activity 
monitors during those activities. CHAMPS has shown reasonable accuracy in comparison to doubly 
labeled water to measure PA in older adults (r= 0.28), 43 and fair to good reliability (ICC= 0.27 to 
0.84) when measuring PA in people with musculoskeletal disorder and healthy older adults. 19,43,44,46-48 
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2.3.4 Reliability of Monitoring Timeframes  
Test-retest reliability of the monitoring timeframes of the ACT and SWA used three pre-specified 
timeframes: ‘24-hours’, ‘wake-hours’ and ‘10-hour from awakening’. These timeframes are 
commonly used in research using activity monitors to assess free-living PA.114 The ‘24-hours’ 
corresponded a whole day of activities, including sleeping time. The ‘wake-hours’ was identified 
from wake-up time to sleep time. The ‘10-hour from awakening’ was determined by counting 10 
hours from wake-up time. Wake-up time and sleep time were identified using the SWA. The SWA 
has shown to be accurate to detect sleep in comparison to the reference standard of 
polysomnography. 129-131 The same times identified using the SWA software were used to identify 
wake-up and sleep times on the ACT. Subjects were entered in the timeframe reliability analysis only 
if they had accelerometry data during ‘24-hours’ and if the monitoring days and times from the ACT 
matched those identified using the SWA. This approach was used to assure that both monitors were 
measuring the same activities performed during the same time. The matching approach is illustrated 
in Figure 6 using data from one subject.  
2.3.5 Data Analysis 
Descriptive statistics for continuous variables included mean and standard deviation or median and 
25-75 percentiles, according to data distribution. Counts and frequencies were used for categorical 
variables. Demographics and biomedical characteristics between subjects who reported about the 
same activities during the two weeks and those who reported more/less activities in week two were 
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compared using Independent Samples T-test or Mann-Whitney U test for continuous data, and Chi-
square test for categorical data.  
 
 
 
Figure 6. Illustration of the approach used to match days of monitoring time between data obtained 
from the SenseWear Armband (SWA) and Actigraph (ACT) during 24 hours.  
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Test-retest reliability of PA measures from week one and week two was determined by intra-
class correlation coefficient (ICC2,k) using absolute agreement. As a general guideline for 
interpretation, ICC<0.5 means poor reliability, ICC between 0.50 to 0.75 represents moderate 
reliability, and ICC>0.75 indicates excellent reliability.108 Measurement error was estimated using the 
Standard Error of Measurement (SEM). The SEM is calculated based on the reliability coefficient 
(ICC) and variance (SD) of PA measures between week one and two using the equation: SEM = SD 
√1-ICC. We also calculated the Minimum Detectable Change (MDC) to provide a threshold within a 
defined level of statistical confidence that change is beyond measurement error using the following 
equation: MDC = z score level of confidence x √2 x SEM. 107,108 We used the z scores of 1.96 
(associated with 95% confidence - MDC95) and 1.65 (associated with 90% confidence - MDC90).  
Bland-Altman plots were used to compare the mean difference between the two weeks of 
measurements, and to assess for systematic bias and outliers.  
To compare the differences between the reliability of PA measures across the ACT, SWA 
and CHAMPS, we examined if the point estimates of the ICC of one of the instruments was 
contained in the 95% confidence intervals of the ICC from another instrument. If the point estimate 
is not within the 95% confidence interval, than the reliability of one instrument is statistically 
significant different from the other. 132 
We also explored if the magnitude of measures of PA differed between the three 
measurement tools. Paired T-test or Wilcoxon signed-rank test were used according to data 
distribution (ACT vs. SWA, ACT vs. CHAMPS, and SWA vs. CHAMPS). Only data from week one 
was used for this analysis. Alpha level was set at 0.05 for all analysis. No attempt was made to 
correct for multiple comparisons in order to minimize type II error. All the analyses were performed 
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using the IBM SPSS Statistics 21 (IBM Corporation), and Microsoft Excel 2010 (Microsoft 
Corporation). 
2.4 RESULTS 
We invited all 44 individuals from the parent trial to participate in this ancillary study. Two subjects 
declined participation because they were not willing to wear the activity monitors for two weeks. 
From the remaining 42 subjects, 7 did not have sufficient data for one of the weeks and were asked 
to wear the monitors for an additional week. Five of these subjects were excluded due to insufficient 
data even after wearing the devices for an additional week. Of the remaining 37 subjects, 9 reported 
more/less activities in week two, leaving 28 subjects with similar PA during both weeks for the 
reliability analysis (Figure 7). On average, The monitoring wear time for these subjects was 21±3 
hours and it was similar during both weeks. The characteristics of subjects who participated in the 
reliability analysis and the ones excluded from the analysis are compared in Table 1.  
Table 2 shows the characterization of PA during the two weeks along with the results from 
test-retest reliability, SEM, and MDC. The three measurement tools showed good to excellent test-
retest reliability (ICC≥ 0.75), with confidence intervals within the range of moderate to excellent 
reliability (95% CI of ICCs: 0.43 to 0.98). Bland-Altman plots revealed no systematic bias between 
measures from the two weeks for the ACT and SWA across intensity categories (Figures 8 and 9). 
However, the plots demonstrated systematic bias for CHAMPS scores in duration of light intensity 
PA and light-to-moderate PA. The line of equality (zero) was not contained within the 95% CI of 
the difference between weeks, and indicated that PA values from week one were significantly higher 
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than those of week two. These differences concur with the significant F-tests from Analysis of 
Variance (from ICC calculation) that tests the difference between PA measures from week one and 
week two (Table 2).  
 
 
 
Figure 7. Flow chart of subjects included in the final analysis. 
 
 
 
 
 
2 denied participation 
50 subjects invited 
48 subjects recruited 
37 subjects with        
sufficient data  
7 subjects were excluded 
as days or times were not 
the same for the activity 
monitors 
 
 
28 subjects reported similar PA 
during the two weeks and were 
used for reliability analysis 
21 subjects with data matched that 
were used for reliability analyses of 
monitoring timeframes  
11 without sufficient data 
(5 days with 10 hours)  
9 subjects reported more 
or less activities in one of 
the weeks 
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Table 1. Demographic and biomedical characteristics of subjects who participated in the reliability 
analysis and subjects excluded from this analysis. Numbers represent mean ± SD, unless otherwise 
indicated. 
 Participated in reliability 
analysis (n= 28) 
Excluded from reliability 
analysis (n= 22) 
 
p-value 
Age in years 68.5 ± 7.4 66.4 ± 5.3 0.383 
Sex – female (%) 22 (76) 12 (55) 0.453 
BMI in kg/m2 29.2 ± 3.8 30.0 ± 4.1 0.836 
Race – white (%) 27 (93) 18 (82) 0.570 
Education – n (%) 
     High-school 
     College 
  0.816 
12 (41) 8 (36) 
17 (59) 14 (64) 
    
    
     1 to 10 years 21 (72) 14 (64)  
     More than 10 years 8 (28) 8 (36)  
Time from TKA – n (%) 
     3 to 4.9 months 
     5 to 6 months 
  0.948 
20 (69) 16 (72) 
9 (31) 6 (28) 
Knee pain – 0 to 10;  
median (Q25; Q75) 
     Surgical side 
     Non-surgical side 
   
 
0.790 
0.624 
  
2 (1; 3) 
3 (0; 6) 
3 (0; 3) 
2 (0; 3) 
WOMAC-PF 19.5 ± 9.1 18.9 ± 12.9 0.308 
P-value of the differences between those who participated and those who were excluded from 
reliability analysis; BMI: body mass index; TKA: total knee arthroplasty; Q25: quartile 25th; Q75: 
quartile 75th; WOMAC-PF: Western Ontario and McMaster Universities Osteoarthritis Index-
Physical Function sub-scale. 
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Table 2. Average duration of physical activity (min/day) and caloric expenditure (kcal/day) measured by the Actigraph (ACT), Sensewear 
Armband (SWA) and CHAMPS questionnaire during two weeks. Intra-class correlation coefficient (ICC) with its corresponding 95% 
confidence interval (95% CI), standard error of measurement (SEM), and minimal detectable change (MDC).  
  PA intensity Week 1 Week 2 
Diff  
(95% CI)  
Significance 
F-test  
ICC  
(95% CI) SEM 
MDC 
90% 
MDC 
95% 
ACT 
Min/day 
Light 67.3±33.0 65.0±36.3 2.2 (-8.5; 13.0) 0.670 
0.86* 
(0.66; 0.94) 13.0 30.3 36.0 
Moderate 11.7±13.0 9.0±8.2 2.6 (-1.5; 6.8) 0.200 
0.75* 
(0.43; 0.89) 5.3 12.4 14.7 
Light to 
moderate 78.9±42.9 74.0±43.2 
4.9 
(-8.8; 18.6) .467 
0.85* 
(0.64; 0.94) 16.9 39.4 46.8 
Kcal/day 
Light 249.7±95.0 246.0±103.4 3.7 (-24.8; 32.2) 0.790 
0.88 
(0.72; 0.95) 34.4 80.2 95.3 
Moderate 73.4±85.0 56.5±60.5 16.9 (-10.5; 44.3) 0.213 
0.77 
(0.47; 0.90) 34.9 81.4 96.7 
Light to 
moderate 323.1±162.0 302.4±153.6 
20.6 
(-27.4; 68.6) 0.382 
0.86 
(0.67; 0.94) 59.0 137.8 163.7 
Number of Steps 4676.8±2031.6 4413.9±1693.9 262.9  (-368.2; 894.1) 0.394 
0.85* 
(0.63; 0.94) 709.2 1654.8 1965.7 
SWA  
Min/day 
Light 138.9 ± 102.8 149.7 ± 98.7 -10.8 (-27.9; 6.3) 0.205 
0.95§ 
(0.90; 0.98) 22.5 52.6 62.5 
Moderate 45.3 ± 44.7 43.5 ± 36.6 1.8 (-6.7; 10.3) 0.669 
0.93 
(0.85; 0.97) 10.8 25.1 29.8 
Light to 
moderate 184.3 ± 138.8 193.2 ± 127.4 
-9.0 
(-32.1; 14.2) 0.433 
0.95 
(0.89; 0.98) 29.8 69.5 82.5 
Kcal/day 
Light 400.9 ± 266.4 445.7 ± 280.5 -44.9 (-102.1; 12.3) 0.119 
0.93§ 
(0.83; 0.97) 77.3 180.5 214.4 
Moderate 213.7 ± 199.7 205.7 ± 180.4 8.0 (-40.5; 56.4) 0.738 
0.89 
(0.76; 0.95) 63.0 147.1 174.7 
Light to 
moderate 614.8 ± 427.0 651.5 ± 421.0 
-36.7 
(-125.2; 51.8) 0.401 
0.93 
(0.84; 0.97) 112.2 261.8 311.0 
Number of Steps 6261.8±3647.5 6371.5±3432.3 -109.7 (-763.2; 543.8) 0.166 
0.95 
(0.88; 0.98) 936.6 2185.5 2596.1 
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Table 2 (continued) 
CHAMPS 
Min/day 
Light 67.8±37.4 58.5±31.6 11.4  (3.0; 19.8) 0.010 
0.86 
(0.66; 0.94) 12.9 30.1 35.8 
Moderate 41.1±39.8 40.0±46.1 0.61 (-8.6; 9.8) 0.892 
0.92¶ 
(0.83; 0.96) 12.2 28.4 33.7 
Light to 
moderate 108.8±57.6 98.5±61.4 
12.0 
(0.18; 23.8) 0.047 
0.92 
(0.82; 0.97) 16.8 39.3 46.7 
Kcal/day 
Light 196.5±106.4 206.4±113.8 -9.9  (-43.9; 24.1) 0.555 
0.82 
(0.60; 0.92) 46.7 109.0 129.5 
Moderate 237.8±322.8 165.4±199.4 72.4 (-0.8; 145.6) 0.052 
0.85 
(0.66; 0.93) 101.1 236.0 280.3 
Light to 
moderate 434.4±359.3 371.9±269.1 
62.5  
(-10.8; 135.8) 0.091 
0.90 
(0.78; 0.95) 99.4 231.9 275.4 
 
* The point estimates of the ICC from ACT were not contained in the 95% CIs of the ICC from SWA; § The point estimates of the ICC 
from SWA were not contained in the 95% CIs of the ICC from CHAMPS; ¶ The point estimates of the ICC from CHAMPS were not 
contained in the 95% CIs of the ICC from ACT; Diff: raw difference between week one and two; Significance of F-test from the Analysis 
of Variance used to calculate ICCs;  
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Blue solid line indicates the mean of the difference between measures from week 1 to week 2. Blue dashed line indicates 95% confidence 
interval around the difference between weeks. Red dashed line indicates the 95% limit of agreement between pooled mean of physial 
activity measures in both weeks. 
Figure 8. Bland and Altman plots from measures of physical activity duration of subjects included in the reliability analysis. 
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Blue solid line indicates the mean of the difference between measures from week 1 to week 2. Blue dashed line indicates 95% confidence 
interval around the difference between weeks. Red dashed line indicates the 95% limit of agreement between pooled mean of physial 
activity measures in both weeks. 
Figure 9. Bland and Altman plots from measures of physical activity caloric expenditure of subjects included in the reliability analysis.
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The comparison of ICC values across measurement tools demonstrated significant lower 
reliability of the ACT as compared to the SWA (Table 2). The ICC estimates of PA duration for the 
ACT in light (ICC= 0.86), moderate (ICC= 0.75), low-to-moderate (ICC= 0.85) intensities, and 
number of steps (ICC= 0.85) were not contained within the 95% CIs of the ICC values for the SWA 
in those intensity categories ([0.89; 0.98], [0.85; 0.97] and [0.90; 0.98], respectively), and number of 
steps (0.88; 0.98). The reliability of the ACT (ICC= 0.75) was also significantly lower compared to 
CHAMPS (95% CI [0.83; 0.96]) in duration of moderate PA, but not for the other variables. The 
reliability of the CHAMPS was significantly lower than that of the SWA for duration (ICC= 0.86 vs. 
95% CI [0.90; 0.98]) and caloric expenditure (ICC= 0.82 vs. 95% CI [0.83; 0.97]) of light intensity 
PA.  
Figures 10 and 11 show duration and caloric expenditure, respectively, measured by the 
ACT, SWA and CHAMPS during week one. Duration of PA and caloric expenditure measured by 
the ACT were significantly lower than that of the SWA across all intensity categories (p<0.050). PA 
measures of duration and caloric expenditure from the ACT were significantly lower than CHAMPS 
in moderate PA (p=0.001 and p=0.004, respectively), duration in light-to-moderate PA (p=0.020), 
and caloric expenditure in light PA (p=0.001). The CHAMPS scores in duration and caloric 
expenditure were significantly lower than measures from SWA in light PA (p=0.004 and p=0.001, 
respectively), and light-to-moderate PA (p=0.018 and p=0.020, respectively). The same analysis was 
run using data from week two and generated very similar results. 
 60 
 
  
* Duration score significantly different between measurement tools (p<0.017); 
Figure 10. Comparison between the magnitude of the duration of physical activity across 
instruments during week one. Actigraph (ACT), Sensewear Armband (SWA) and CHAMPS 
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* Caloric expenditure score significantly different between measurement tools (p<0.017); 
Figure 11. Comparison between the magnitude of the caloric expenditure of physical activity across 
instruments during week one. Actigraph (ACT), Sensewear Armband (SWA) and CHAMPS.  
 
 
2.4.1 Reliability of Monitoring Timeframes  
Seven of the 28 subjects from the reliability analysis either did not have data during ‘24-hours,’ or 
their PA data from ACT and SWA did not match the same monitoring days and times. Amongst the 
21 subjects included in this analysis, the minimum wear-time was 22:47 hr/day. The reliability of 
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monitoring timeframes is described in Tables 3, 4 and 5 (‘24-hours,’ ‘10-hour from awakening,’ and 
‘wake-hours,’ respectively). Reliability of the ACT and SWA in each of the monitoring timeframes 
ranged from moderate to excellent (ICC= 0.75 to 0.96). To simplify interpretation, these tables 
report PA data in min/day only, since PA data in min/day and kcal/day were highly correlated 
across all timeframes (Spearman’s rho from 0.85 to 0.96).  
The reliability of the ACT and SWA in monitoring timeframes ranged from good to 
excellent (ICC= 0.75 to 0.96). The ICCs for each instrument were similar across all timeframes and 
indicated no statistical differences. However, there was a trend towards higher ICCs with narrower 
confidence intervals in the ‘wake-hours’ and ‘10-hours from awakening’ in comparison to ‘24-hours’ 
timeframe. Bland-Altman plots revealed no systematic bias between PA measures from the two 
weeks for the ACT and SWA across intensity categories and timeframes (Figures 12-14).  
2.5 DISCUSSION 
This is the first study to concurrently determine the test-retest reliability of the ACT, SWA, and 
CHAMPS during free-living PA performed in light and moderate intensities after TKA. Results of 
the reliability analysis revealed good test-retest reliability for the three instruments. Measures of PA 
from the SWA have shown to be more reliable than those of the ACT and CHAMPS. PA duration 
measured by the SWA showed better reliability than measures from the ACT across all PA 
categories, and was also better than measures of light-intensity PA from the CHAMPS. The better 
reliability of PA measures from the SWA is further supported by the lower bounds of the 95% CIs 
that were consistently above the threshold of excellent reliability, i.e., ICC>0.75. 
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Table 3. Daily physical activity duration (min/day), intra-class correlation coefficient (ICC) and measurement error from 21 subjects with 
data matched between Actigraph (ACT) and Sensewear Armband (SWA) in the 24-hour timeframe during the two weeks of data collection. 
  Activity  Intensity 
Week 1 
Mean ± SD 
Week 2 
Mean ± SD 
Diff   
(95% CI) 
Significance 
F-test 
ICC  
(95% CI) SEM 
MDC 
90% 
MDC 
95% 
ACT 
Light 65.5±34.2 66.3±37.9 0.2 (-11.4; 11.8) 0.970 
0.86  
(0.64; 0.94) 13.5 31.4 37.3 
Moderate 10.4±12.8 8.7±8.0 1.7 (-2.7; 6.1) 0.429 
0.75  
(0.46; 0.90) 5.2 12.1 14.4 
Light to 
moderate 76.9±44.0 75.0±44.8 
1.9 
(-12.8; 16.6) 0.790 
0.84  
(0.61; 0.94) 17.7 41.3 49.0 
Steps 4570.1±2041.1 4374.4±1683.6 195.6 (-404.2; 795.5) 0.501 
0.89  
(0.70; 0.96) 615.7 1436.7 1706.6 
SWA 
Light 135.8±89.8 148.9±92.6 -13.1 (-34.6; 8.4) 0.219 
0.93  
(0.82; 0.97) 23.3 54.4 64.6 
Moderate 45.3±39.8 43.8±34.1 1.5 (-8.1; 11.1) 0.750 
0.91  
(0.79; 0.97) 11.0 25.7 30.5 
Light to 
moderate 181.1±118.1 192.6±116.1 
-11.6 
(-39.7; 16.5) 0.400 
0.93  
(0.82; 0.97) 30.1 70.2 83.4 
Steps 6104.1±3505.8 6095.8±3133.6 8.3 (-759.1; 775.6) 0.982 
0.92  
(0.81; 0.97) 923.4 2154.7 2559.5 
Significance of  F-test from the Analysis of  Variance used to calculate ICCs; SEM: Standard Error of  the Measurement; MDC: Minimal 
Detectable Change.  
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Table 4. Daily physical activity duration (min/day), intra-class correlation coefficient (ICC) and measurement error from 21 subjects with 
data matched between Actigraph (ACT) and Sensewear Armband (SWA) in the 10-hours from awakening timeframe during the two weeks 
of data collection. 
  Activity  Intensity 
Week 1 
Mean ± SD 
Week 2 
Mean ± SD 
Diff   
(95% CI) 
Significance 
F-test 
ICC  
(95% CI) SEM 
MDC  
90% 
MDC  
95% 
ACT 
Light 50.3±29.7 47.3±28.9 2.9 (-6.7; 12.5) 0.531 
0.88  
(0.71; 0.95) 9.8 22.8 27.1 
Moderate 7.7±8.5 6.7±6.7 1.0 (-1.7; 3.6) 0.449 
0.85  
(0.63; 0.94) 3.0 6.9 8.2 
Light to 
moderate 57.9±35.8 54.0±34.7 
3.9 
(-7.5; 15.4) 0.484 
0.89  
(0.72; 0.95) 11.3 26.3 31.2 
Steps 3325.2±1483.5 3237.6±1316.4 87.6 (-286.6; 461.7) 0.628 
0.92  
(0.80; 0.97) 396.7 925.8 1099.7 
SWA 
Light 102.1±67.2 109.6±62.9 -7.5 (-22.4; 7.5) 0.309 
0.94  
(0.86; 0.98) 16.3 38.0 45.2 
Moderate 36.5±35.5 34.9±27.7 1.5 (-7.1; 10.2) 0.713 
0.92  
(0.80; 0.97) 9.2 21.4 25.4 
Light to 
moderate 138.6±94.7 144.7±83.1 
-6.1 
(-27.4; 15.1) 0.556 
0.94  
(0.85; 0.98) 22.3 52.1 61.9 
Steps 4501.2±2894.5 4515.3±2422.0 -14.1 (-666.2; 638.0) 0.965 
0.95  
(0.87; 0.98) 620.1 1447.0 1718.9 
Significance of F-test from the Analysis of Variance used to calculate ICCs; SEM: Standard Error of the Measurement; MDC: Minimal 
Detectable Change. 
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Table 5. Daily physical activity duration (min/day), intra-class correlation coefficient (ICC) and measurement error from 21 subjects with 
data matched between Actigraph (ACT) and Sensewear Armband (SWA) in the wake-hours timeframe during the two weeks of data 
collection. 
   Activity Intensity 
Week 1 
Mean ± SD 
Week 2 
Mean ± SD 
Diff   
(95% CI) 
Significance 
F-test 
ICC  
(95% CI) SEM 
MDC 
90% 
MDC  
95% 
ACT 
Light 64.0±33.3 63.6±37.4 0.3 (-11.5; 12.2) 0.956 
0.86  
(0.66; 0.94) 13.2 30.7 36.5 
Moderate 9.9±12.8 8.3±7.7 1.6 (-2.8; 5.9) 0.456 
0.82  
(0.56; 0.93) 4.9 11.4 13.6 
Light to 
moderate 73.8±42.9 71.9±43.9 
1.9 
(-13.0; 16.8) 0.794 
0.86  
(0.65; 0.94) 16.3 37.9 45.1 
Steps 4506.2±2045.4 4352.1±1693.3 154.1 (-446.1; 754.3) 0.595 
0.89  
(0.70; 0.96) 617.9 1441.2 1712.8 
SWA 
Light 134.0±88.9 147.7±91.0 -12.7 (-34.0; 8.6) 0.226 
0.94  
(0.85; 0.98) 22.3 52.1 61.9 
Moderate 45.1±39.6 43.8±34.3 1.3 (-8.3; 10.9) 0.780 
0.93  
(0.83; 0.97) 9.9 23.2 27.5 
Light to 
moderate 180.1±117.6 191.5±114.8 
-11.5 
(-39.3; 16.4) 0.402 
0.94  
(0.85; 0.98) 28.9 67.5 80.2 
Steps 5991.5±3482.7 6001.5±3127.4 -10.0 (-773.6; 753.7) 0.979 
0.96  
(0.89; 0.98) 686.1 1601.0 1901.8 
Significance of F-test from the Analysis of Variance used to calculate ICCs; SEM: Standard Error of the Measurement; MDC: Minimal 
Detectable Change. 
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Blue solid line indicates the mean of the difference between measures from week 1 to week 2. Blue 
dashed line indicates 95% confidence interval around the difference between weeks. Red dashed line 
indicates the 95% limit of agreement between pooled mean of physial activity measures in both 
weeks. 
Figure 12. Bland and Altman plots from measures of physical activity during 24-hours timeframe. 
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Blue solid line indicates the mean of the difference between measures from week 1 to week 2. Blue 
dashed line indicates 95% confidence interval around the difference between weeks. Red dashed line 
indicates the 95% limit of agreement between pooled mean of physial activity measures in both 
weeks. 
Figure 13. Bland and Altman plots from measures of physical activity during 10-hours from 
Awakening timeframe. 
 68 
 
 
Blue solid line indicates the mean of the difference between measures from week 1 to week 2. Blue 
dashed line indicates 95% confidence interval around the difference between weeks. Red dashed line 
indicates the 95% limit of agreement between pooled mean of physial activity measures in both 
weeks. 
Figure 14. Bland and Altman plots from measures of physical activity during Wake-hours 
timeframe.
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Better reliability of the SWA as compared to the ACT is supported by consistent higher ICC 
values for the SWA both in duration of PA (ICCs for SWA ranged from 0.93 to 0.95 whereas ICCs 
for ACT ranged from 0.75 to 0.86), and caloric expenditure (ICCs for SWA ranged from 0.89 to 
0.93 whereas ICCs for the ACT ranged from 0.77 to 0.86). Despite the consistent differences in ICC 
values between activity monitors, these differences were only significant for duration of PA and not 
for caloric expenditure. The reason for this inconsistency is probably because the differences in 
ICCs between ACT and SWA for caloric expenditure were slightly smaller than the differences in 
ICC for duration of PA. Differences in the ICC values from caloric expenditure (SWA minus ACT) 
were 0.05 for light (0.93 minus 0.88), 0.12 for moderate (0.89 minus 0.77), and 0.07 for light-to-
moderate intensity PA (0.93 minus 0.86) whereas for PA duration, these differences were 0.09 for 
light (0.95 minus 0.86), 0.18 for moderate (0.93 minus 0.75), and 0.10 for light-to-moderate (0.95 
minus 0.85). The SWA also demonstrated superior reliability in comparison to CHAMPS in light 
intensity PA. The better reliability of the SWA is further supported as it was the only instrument 
with lower bounds of 95% CIs consistently above the threshold of good reliability, i.e., ICC>0.75. 
Unlike the ACT and SWA, the CHAMPS had systematic bias with higher scores in week one 
as compared to week two in light and light-to-moderate PA. Despite high reliability for these 
categories (ICC> 0.85), this finding questions the ability of this questionnaire to provide consistent 
scores. High ICC values along with systematic bias can be explained by the relative higher between-
subject variability as compared to within-subject variability. In our study, the range of differences in 
PA duration between weeks (week one minus week two) was much higher for between-subjects than 
within-subjects. For example, the difference between weeks for light intensity PA between-subjects 
ranged from -77 to 81 min/day, and within-subject differences ranged from -11 to 81 min/day.  We 
only provide example for light intensity PA because systematic bias in light-to-moderate was 
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attributed to the contribution of light intensity measures since the moderate intensity category did 
not demonstrate systematic bias. We believe the differences in self-report of PA between both 
weeks were not due to true changes in PA behavior since we did not observed systematic bias in the 
objective measures from the activity monitors. The differences in CHAMPS may have occurred due 
to the subject’s difficulty in recalling light intensity PA. 48,93 Since most of the activities at this 
intensity are those of daily-living, individuals may not keep track of how many times per week or for 
how long tasks such as sweeping or walking to grocery store are performed. Whereas, reporting 
moderate PA such as exercise walking or strength training tend to be easier, since these activities are 
purposefully done for exercise and may be performed fewer times per week.  
Although our results for the SWA cannot be put in perspective with literature because no 
prior studies determined the reliability of PA measures from the SWA in free-living, they can be 
compared to studies on the ACT and CHAMPS. Yet, studies on the ACT and CHAMPS 
investigated the reliability of PA measures from each instrument separately rather than concurrently 
in the same study. The studies on the ACT were done in healthy middle-aged and older adults, and 
reported ICCs ranging from 0.74 to 0.90.70,120 Although the ICCs from our study fall within the 
range of ICCs from those studies, their findings cannot be generalized to our population, since older 
adults with knee osteoarthritis who undergo TKA tend to be less active than their healthy and 
younger counterparts.1 Several studies in healthy older adults investigated the reliability of CHAMPS 
and reported lower reliability compared to our study (ICC= 0.62 to 0.81).19,44,46,48 A study in adults 
with fibromyalgia also reported lower reliability than ours (ICC= 0.27 to 0.76).47 Amongst these 
studies, only one used one-week interval to determine the reliability of PA measured by the 
CHAMPS and reported estimates (ICC= 0.79 to 0.81)46 comparable to ours (ICC= 0.82 to 0.92). 
The lower ICCs reported in the other studies could be attributed to the longer time interval between 
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test-retest that ranged from 2-weeks to 6-months. Future larger studies should investigate the 
comparative reliability of activity monitors and questionnaires using different test-retest intervals.   
Our study also provided the SEM and MDC values for the PA measures and is unique in 
this regard. We are not aware of other studies that reported these indices of measurement error of 
PA measured by the ACT, SWA or CHAMPS. The SEM and MDC use the same units as the 
measurement, and are clinically useful because they can be used to interpret changes in PA that are 
beyond measurement error. While the SEM represents the value of measurement error itself, the 
MDC uses the SEM to compute a threshold within a defined level of statistical confidence that true 
change has occurred beyond measurement error. We reported the MDC with two degrees of 
confidence, the MDC90 and MDC95, so one can choose how strict to be when making interpretation 
of changes in PA overtime. For instance, using the MDC90 for duration in light-intensity PA 
measured by the SWA (53 min/day), if a person increases time in light activities by greater than 53 
min/day, one can be 90% confident that there was a real change in PA that is beyond measurement 
error. Although 53 min/day seems to be a large change, it must be noted that activities falling in this 
intensity category (2 to 2.9 METs), are those including mopping, gardening and slow walking, which 
are spread throughout the day and are doable for individuals with arthritis of the lower extremities.  
When the magnitude of PA values was compared across instruments, we observed that PA 
values from the ACT were consistently lower than those from the SWA, and lower than those from 
CHAMPS in moderate PA. To date, a couple of studies in young adults compared measures of PA 
concurrently using the ACT and SWA in free-living conditions, and reported lower PA values 
measured by the ACT in comparison to SWA. 55,57,115 To our knowledge, one study compared the 
magnitude of values between the ACT, SWA and CHAMPS in healthy older adults. 43 The study 
used the ACT, SWA and CHAMPS to measure PA energy expenditure, which is a measure of all 
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activities performed excluding resting. Their results indicated that measures of PA from the ACT 
were higher than the SWA, and that the SWA measures were similar to CHAMPS. The divergence 
between results might be due to the different methodologies they used to calculate caloric 
expenditure from the PA instruments. While we used the equations recommended by the ACT, 
SWA and CHAMPS to calculate PA at different intensities, the authors of that study used 
questionable approaches. For example, when using the ACT, Freedson equation was used to 
calculate caloric expenditure for all activities regardless of intensity level. Yet, Freedson equation was 
developed to calculate energy expenditure of moderate intensity activities. Using the incorrect 
equation would overestimate energy expenditure. The same authors calculated energy expenditure 
for the CHAMPS by subtracting resting energy expenditure from the total score. This approach is 
not appropriate since CHAMPS total score does not include resting. However, we were able to 
compare the results of our study to theirs on the number of steps a day measured by the ACT and 
SWA. Their findings of lower number of steps from the ACT (5917 steps a day) as compared to 
SWA (7022 steps a day) agreed with our results (4677 vs. 6262). This finding adds to the volume of 
literature on the limitations of the ACT in measuring number of steps in slow walkers such as older 
adults with functional limitations. 133-135 Furthermore, a recent study in individuals who underwent 
TKA has shown that measures from the ACT consistently underestimate the SWA in a variety of 
activities. 84 Combined, these findings support that the SWA seems to be more appropriate to 
measure PA in individuals with osteoarthritis of the lower extremities. 
Our study is also the first to provide evidence on the comparative reliability of the activity 
monitors across different monitoring timeframes. While evidence on the number of days to wear 
activity monitors is robust, little is known about the consistency of PA measures across different 
daily wear-periods. Our results indicated that the reliability of the ACT and SWA seems comparable 
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across timeframes; however, the information given by ‘10-hours from awakening’ may not provide a 
good representation of daily activities. In comparing the amount of PA data contained in the ‘10-
hours from awakening’ to the ‘24-hours’, the 10-hours had 19% ([36.5 min/day from 10-
hours]/[45.3 min/day from 24-hours in moderate PA from SWA]) to 29% ([47.3 min/day from 10-
hours]/[66.3 min/day from 24-hours in light intensity PA from ACT]) less moderate and light 
intensity PA data respectively. Whereas, the ‘wake-hours’ had only 0% to 5% less PA data compared 
to ‘24-hours’. These differences between timeframes are in line with a study in healthy adults that 
measured PA using the ACT and reported that PA measured during a 10-hours period resulted in up 
to 42% less PA data as compared to a 14-hours period (wake-hours). 114 Using data from periods 
shorter than wake-hours result in underrepresentation of daily PA since many people tend to spread 
their activities throughout the day. For example, a person wakes up at 6:30 am, does some 
household chores such as cleaning, goes to work at 8 am, sits at the office desk until 5 pm, and goes 
to the gym at 6 pm. If PA is measured during ‘10-hours from awakening’, all the activities carried 
out after 4:30 pm would not be measured, including going to the gym, which represented a relevant 
PA in this example. Therefore, the ‘wake-hours’ seems to be the most appropriate monitoring 
timeframe to use since it will capture most of the activities performed in 24-hour period and 
provides reliable PA measures. In addition, measuring PA during wake-hours will reduce burden on 
subjects, as most of them feel uncomfortable wearing the monitors while sleeping. Also, the data 
processing for ‘wake-hours’ is less cumbersome than for ‘10-hours from awakening’. 
We acknowledge that our study had a small sample size. Although our primary analysis had 
only 28 subjects, it did not seem to have negatively affected the ICC results as the values had 
generally narrow confidence intervals. Another limitation was that indices of measurement error 
were calculated based on one-week interval. We also acknowledge that estimates of reliability and 
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measurement error may be different for longer time intervals. In addition, although our sample was 
a good representation of individuals with knee osteoarthritis who undergo TKA, our results may not 
be generalized to healthy older adults without dysfunctions of the lower extremities. 
2.6 CONCLUSION 
Our results indicated that duration of PA measured by the SWA is more reliable than measures from 
the ACT across intensity categories, and more reliable than measures of light-intensity PA from 
CHAMPS. Measuring daily PA using the ACT or CHAMPS may not be ideal because the ACT 
measures significantly lower PA than the SWA and CHAMPS, and measures of light-intensity PA 
from the CHAMPS were significantly different between weeks. Furthermore, it seems that 
monitoring PA during wake-hours provides reliable data that resemble the 24-hours timeframe. 
Using the wake-hours monitoring timeframe may help reduce burden on subjects without 
compromising reliability when wearing activity monitors. 
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3.0 CHAPTER 3 - RESPONSIVENESS OF PHYSICAL ACTIVITY MEASURES 
FOLLOWING EXERCISE PROGRAMS AFTER TOTAL KNEE ARTHROPLASTY 
3.1 SUMMARY 
Background: Few instruments that measure physical activity (PA) can accurately quantify PA 
performed at light and moderate intensities, which is particularly relevant to older adults. However, 
evidence of their responsiveness after an intervention is limited. Objectives: To determine and 
compare the responsiveness of two activity monitors (Actigraph [ACT]) and Sensewear Armband 
[SWA]) and one questionnaire (Community Healthy Activities Model Program for Seniors 
[CHAMPS]) in assessing PA in light and moderate intensities after an exercise intervention in 
individuals following total knee arthroplasty (TKA). Design: One-group pretest-posttest. Methods: 
Changes in duration of daily PA from baseline to 6 months and the standardized response mean 
(SRM) were calculated to assess internal responsiveness, and were compared across instruments. 
Correlations between measured changes by the three instruments and perceived changes in PA 
assessed by a global rating of change at 6 months were used to test external responsiveness. 
Agreement between instruments in identifying changes in PA based on measurement error was 
determined using weighted-Kappa. Results: Thirty subjects, mean age 67(6) and 73% female, were 
included in the analysis. Changes in PA measured by each instrument were small and not significant 
(p>0.05). SRMs indicated small degree of responsiveness (SRM<0.30). Scores in the global rating of 
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change did not correlate with changes measured by the instruments (rho=0.05-0.28, p>0.05). ACT 
and SWA agreed on identifying changes in moderate-intensity PA (K=0.60) and number of steps 
(K=0.63). There was no agreement between CHAMPS and the activity monitors (K≤0.22). 
Conclusion: The measurement tools had similar small degree of internal responsiveness. Using 
measurement error as a threshold allowed identification of individual changes in PA and might be an 
alternative to investigate changes in PA in future studies. 
3.2 INTRODUCTION 
The benefits of regular physical activity (PA) to improve general health are well known. Being 
physically active can lower the risk for certain comorbid conditions such as heart disease, stroke, 
type 2 diabetes, depression, some cancers, and obesity.109 Individuals who undergo total knee 
arthroplasty (TKA) for end-stage knee osteoarthritis are typically older adults who are less active 
than their healthier counterparts and are at greater risk of developing co-morbidities.110-113 
Interventions to increase PA and prevent co-morbidities in individuals after TKA have received 
increased attention among the research community lately.136,137 To test the effectiveness of 
interventions to increase PA, researchers need measurement tools that are sensitive to changes in PA 
behavior. However, information on the responsiveness of instruments that measure PA behavior is 
limited.  
Responsiveness evaluates the ability of a measurement tool to accurately detect changes in 
the construct being measured when change has occurred and it can be determined by internal and 
external responsiveness methods.7,13,14 The internal responsiveness method is based on the 
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distribution of the data and represents the ability of a group measure to change over time in 
response to an intervention. This method can be quantified by indices such as effect sizes that are 
calculated using the magnitude of the change and its variability.14 Since this method is based on 
group change, it is suitable to determine changes that occur at the group level. For the external 
responsiveness method, an external anchor that assesses perceived changes in PA by the individual 
is used to compare to individuals changes in PA detected by the measurement tools being tested. 
This method is used to determine the amount of change in the measurement that corresponds to 
change that is perceived as important to the individual and can be used to calculate clinically 
meaningful thresholds for changes at the individual level.   
There are numerous tools available to measure PA, including activity monitors and self-
report questionnaires, but evidence of their ability to capture change in PA over time is limited. Two 
activity monitors and one self-report questionnaire have been commonly used in research 
investigating older population such as those after TKA. The Actigraph (ACT; Actigraph LLC, 
Pensacola, FL), worn at the waist level, and the Sensewear Armband (SWA; Bodymedia, Pittsburgh, 
PA), worn on the arm, are activity monitors that have been validated to measure PA in older 
adults.43,84 The Community Health Activities Model Program for Seniors (CHAMPS) was specifically 
developed to measure self-reported PA in older adults.44 These three instruments have the advantage 
to measure PA at light intensities such as household chores and slow walking, which represent most 
of daily activities performed by older adults who undergo TKA.19,48,115-118 While the activity monitors 
are costly and need to be worn for several days to provide representative data of daily activities, the 
questionnaire has low cost and takes 15-20 minutes to complete and recalls activities from past 
week. On the other hand, the activity monitors measure PA in real time, which eliminates the 
problem of recall bias that is commonly faced with self-report PA measures.48,119 
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To our knowledge, no studies have determined the responsiveness of the SWA and the few 
studies on the responsiveness of the ACT and CHAMPS did not include older adults with mobility 
problems.44,138-140 Results from these studies may not be applicable to older adults who underwent 
TKA, since pain and functional limitations associated with knee osteoarthritis make them less active 
than younger people and their healthy older counterparts.1 Additionally, studies have not 
concurrently compared the responsiveness of these three commonly used instruments. Concurrently 
comparing the responsiveness of PA measures estimated by the ACT, SWA and CHAMPS will 
provide information for a well-educated choice of tools to assess changes in PA behavior over time 
in individuals with osteoarthritis of the lower extremities. Hence, the purpose of this study was to 
determine and compare the responsiveness of the ACT, SWA, and CHAMPS in assessing PA from 
light, moderate and vigorous intensities after rehabilitation that involved exercise and physical 
activity promotion programs in individuals who underwent TKA.   
3.3 METHODS  
3.3.1 Design and Subjects 
This was an ancillary study that used a one-group pretest-posttest design. Baseline and 6-month data 
on PA from subjects participating in a randomized trial that investigated the effect of rehabilitation 
approaches to improve physical function in individuals following TKA were analyzed.137 This study 
took place from October 2011 to August 2013 in the Department of Physical Therapy, University of 
Pittsburgh. All subjects signed a consent form approved by the University of Pittsburgh Institutional 
Review Board prior to participation. 
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The inclusion and exclusion criteria followed that of the parent study.137 Individuals with 
unilateral TKA in the past 3-6 months and at least 50 years of age were included. Those who 
reported more than two falls within the past year, were unable to ambulate a distance of 31 meters 
without an assistive device, and had medical conditions that precluded safe exercise participation 
were excluded. Specific to this ancillary study, individuals were included only if they were willing to 
wear the activity monitors for 7 days during baseline and 6-month follow-up.   
3.3.2 Study Protocol 
Subjects attended two testing visits, one prior to the rehabilitation program (baseline), and one at the 
end of the program 6 months after baseline. During the baseline assessment, in order to characterize 
the sample, the subjects completed questionnaires of demographics, pain and physical function. Pain 
was assessed by an 11-point numeric pain scale and physical function by the 17-item Western 
Ontario and McMaster Universities Osteoarthritis Index-Physical Function subscale. Subjects’ height 
and weight were also measured. After finishing the testing procedures at baseline, subjects were 
fitted with the ACT and SWA and were instructed to wear the monitors for 7 days, except during 
water activities since the activity monitors are not waterproof. At the end of the 7-day period, 
subjects returned to the research facility to download the data from the activity monitors and to 
complete the CHAMPS. The CHAMPS questionnaire queries PA participation in the past week, 
which corresponds to the time they wore the monitors. Data from the activity monitors were 
inspected to assure sufficient data, which was defined as at least 5 days with 10-hours of PA data per 
day.122,126 Subjects without sufficient data were asked to wear the portable monitors for an additional 
week and to complete the CHAMPS at the end of that week.  
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After completing the baseline measures of PA, subjects were randomized into two exercise 
groups, which were combined for the purpose of this study. Both exercise programs included 
endurance and strengthening for the lower extremities, with the experimental group performing 
more intense training than the control. In addition, the experimental group was exposed to balance 
and functional exercises as well as a behavioral PA promotion program. The exercise programs 
consisted of 12 supervised sessions delivered within a 3-month period followed by a home exercise 
program for another 3 months.137 
The PA measures from baseline were repeated at 6-month follow-up. In addition, subjects 
were asked to rate how they perceived the overall change in PA since the beginning of the exercise 
program using a modified global rating of change scale. The scale consists of 15 points that range 
from -7 (“a very great deal less active”) to 0 (“about the same”) to +7 (“a very great deal more 
active”). Descriptors of improvement range from +1 to +7, and of worsening, range from –1 to –7. 
Subjects with a rating of +3 ("somewhat more active") or higher were classified as ‘more active’. 
Subjects with a rating between +2 ("a little bit more active") to –2 ("a little bit less active) were 
classified as ‘not changed’. Subjects with a rating of –3 ("somewhat less active") or lower were 
classified as ‘less active’.  
3.3.3 Measures of Physical Activity 
The ACT is a small triaxial accelerometer-based monitor (2 x 1.5 x 0.6 inches in size) worn around 
the waist at the level of the hip-bone and over the right anterior superior iliac spine. In this study we 
used the ACT model GT3X and the ActiLife 5 software (Actigraph LLC, Pensacola, FL). The ACT 
measures body acceleration in activity counts, and was set to collect data at 1-minute intervals. The 
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ACT generates data on activity counts per minute (CPM) and number of steps. To categorize 
duration of daily activities in min/day, the software uses the following CPM cut-points: 760-1951 
CPM for light, CPM 1952-5724 for moderate and >5724 CPM for vigorous intensities. 128 The ACT 
uses body weight to generate measures of caloric expenditure in kcal/day. The equations 
recommended by the manufacturer were used to convert PA duration into caloric expenditure in 
kcal/min. The non-wear periods are calculated by the software following the manufacturer’s 
recommendation and were also visually analyzed. Measures of PA from the ACT have demonstrated 
moderate accuracy as compared to doubly labeled water in older adults and good reliability in older 
adults after TKA. 43,141 
The SWA is a small multi-sensor device (3.4 x 2.1 x 0.8 inches in size) worn on the back of 
the right arm over the triceps muscle and at midpoint between shoulder and elbow. We used the 
SWA model Pro-3 and the Professional software v6.1 (BodyMedia Inc., Pittsburgh, PA). This device 
has shown to be accurate in comparison to doubly labeled water in older adults and good reliability 
in older adults after TKA. 43,141 The SWA combines information from biaxial accelerometer, heat 
flux (heat being dissipated by the body), galvanic signal (onset, peak and recovery of maximal sweat 
rates) and skin temperature. The information from the sensors is integrated and processed by the 
software using proprietary algorithms that account for subjects’ demographic characteristics (gender, 
age, height and weight). The SWA was set to provide data on number of steps, duration of activities 
(min/day), and caloric expenditure (kcal/day) in light (2 to 2.9 metabolic equivalents [METs]), 
moderate (3 to 5.9 METs) and vigorous intensities (≥6 METs), and number of steps. The SWA 
turns off automatically when not in contact with the skin, which enables the software to recognize 
periods of non-wear. Data were also visually screened to identify non-wear periods.  
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The CHAMPS is a self-reported questionnaire that queries type, frequency and duration of 
41 activities usually performed by older adults, ranging from light to vigorous intensities. Duration in 
hours per week (hr/week) of each activity is selected from a range of less than one hour per week to 
9 or more hours per week and categorized in two intensity levels according to the CHAMPS 
activities codebook. 44 Light-to-moderate PA (≥2 METs) represent all exercise-related activities, 
such as light to heavy household chores, and recreational and sports activities. Moderate intensity 
activities (≥3 METs) represent activities such as heavy household chores, calisthenics and sports. To 
allow direct comparison between the CHAMPS and the activity monitors, the score from moderate 
activities was subtracted from that of light-to-moderate to create a light-intensity category for the 
CHAMPS. The CHAMPS also calculates caloric expenditure using equations that take into account 
the intensity of each activity and accounts for subjects’ body weight. 44 Scores from the CHAMPS in 
hr/week and kcal/week were converted into min/day and kcal/day respectively by multiplying the 
duration score by 60 minutes and then dividing by 7 days. CHAMPS has shown significant 
association when compared to doubly labeled water in older adults, and moderate reliability in 
people with musculoskeletal disorder and healthy older adults. 43,47,141 
The main outcome measure of this study was PA in minutes per day (min/day) estimated by 
the ACT, SWA and CHAMPS during waking hours. For each instrument PA was estimated at light 
(e.g., recreational activities, slow walk), moderate (e.g., vacuuming, brisk walk), and vigorous (e.g., 
lawn mowing, doubles tennis) intensity. The measures of moderate and vigorous-intensity activities 
were combined into the moderate category since our sample engaged in negligible amounts of 
vigorous-intensity activities (< 1 min/day). We also assessed daily number of steps using the ACT 
and SWA. Therefore, the PA intensity categories compared across the three instruments in this 
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study were light, moderate, and light-to-moderate (combination of light and moderate intensities); 
and number of steps was compared between the ACT and SWA only.  
3.3.4 Data Analysis 
Descriptive statistics for continuous variables included mean and standard deviation or median and 
25-75 percentiles, according to data distribution. Counts and frequencies were used for categorical 
variables. To visually assess changes in PA we calculated magnitude of changes in PA from pre to 
post intervention (6-months minus baseline) and plotted histograms with those data.  Internal 
responsiveness was determined using paired t-tests or Wilcoxon signed-rank tests comparing PA 
values from baseline to 6-month follow-up. Alpha level was set at 0.05. Additionally, the 
standardized response mean (SRM) was calculated as an index of responsiveness. The SRM is 
calculated as the ratio of mean change to the standard deviation of the change scores. 108 Values 
obtained from the SRM are interpreted as trivial degree of responsiveness (<0.20), small degree of 
responsiveness (0.20 to 0.49), moderate degree of responsiveness (0.50 to 0.79) and high degree of 
responsiveness (≥0.80). 108 
To determine external responsiveness, we first explored if the modified global rating of 
change was suitable as an external anchor to capture perceived changes in PA, meaning that its 
scores would correlate at least moderately (≥0.30) with changes measured by the ACT, SWA and 
CHAMPS. Correlations were calculated using Pearson or Spearman rho correlation coefficients 
according to data distribution. If the scores on the global rating of change correlated with changes in 
PA measured by the three instruments, cut-offs of clinically important change were calculated based 
on receiver operating characteristic (ROC) curves. 14  
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To compare responsiveness across the PA measurement tools one-way repeated measures 
Analysis of Variance (ANOVA) was used for each PA intensity category to determine if the 
magnitude of change obtained from the three instruments were statistically different from each 
other. Since the three instruments were used to assess changes in PA in the same subjects, changes 
in PA at each intensity category measured by each instrument was used as the repeated factor. If the 
ANOVAs revealed significant differences, paired samples t-tests were used for the post hoc 
comparisons between PA measures applying Bonferroni adjustments. The alpha level was set at 
0.016 to account for the three comparisons (ACT vs. SWA, SWA vs. CHAMPS, ACT vs. 
CHAMPS). Responsiveness was also compared by examining the 95% confidence intervals of the 
SRM. If the 95% confidence intervals did not overlap, the responsiveness of one instrument was 
deemed significantly different from the other. 132 In addition, weighted Kappa was used to 
investigate the agreement between instruments on identifying subjects who were had less, more, or 
about the same PA after the intervention, based on the standard error of the measurement 
previously published. 141 Values obtained from weighted Kappa are interpreted as poor (<0.20), fair 
(0.21-0.40), moderate (0.41-0.60), good (0.61-0.80) and very good (0.81-1.00). 142 Analyses were 
performed using the IBM SPSS Statistics 21 (IBM Corporation) and Microsoft Excel 2010 
(Microsoft Corporation). 
3.4 RESULTS 
Forty-two subjects completed the randomized clinical trial, of which 30 had baseline and follow-up 
data for the three PA measurement tools and were included in the responsiveness analyses. The 
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demographic and biomedical characteristics between subjects included and those excluded from the 
responsiveness analyses were similar (Table 6). Subjects included in the responsiveness analyses were 
on average 67±6 years old, predominantly females (73%) and obese (body mass index = 30±4 
kg/m2). The daily monitoring wear time was on average 15±2 hours per day and was similar at 
baseline and follow-up. 
 
Table 6. Baseline characteristics of study sample.  
Variables 
Included in  
Responsiveness Analysis 
n=30 
Not Included in 
Responsiveness Analysis 
n=12 
Age in years 67.3 (6.2) 69.8 (7.2) 
Sex – female (%) 22 (73.3) 8 (66.7) 
BMI in kg/m2 29.9 (4.1) 31.0 (3.6) 
Race – white (%) 27 (90.0) 10 (83.3) 
Education – n (%) 
     High-school 
     College 
  
12 (40.0) 4 (33.3) 
18 (60.0) 8 (66.7) 
Time from TKA – n (%) 
     3 to 4 months 
     4 to 5 months 
5 to 6 months 
  
7 (23.3) 4 (33.3) 
13 (43.3) 4 (33.3) 
10 (33.4) 4 (33.4) 
Knee pain – 0 to 10; median (Q25; Q75) 
     Surgical side 2 (1; 3)  3 (1; 3) 
     Non-surgical side 3 (0; 5) 3 (1; 6) 
WOMAC-PF – 0 to 68;  19.1 (9.5) 18.6 (10.5) 
SD: standard deviation; BMI: body mass index; TKA: total knee arthroplasty; Q25: quartile 25th; 
Q75: quartile 75th; WOMAC-PF: Western Ontario and McMaster Universities Osteoarthritis Index-
Physical Function sub-scale;  
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 Figure 15 depicts the distribution of changes in PA from baseline to follow-up. The graphs 
indicate that the number of subjects who became less active, more active, and those who did not 
change PA was similar. For example, based on zero as a threshold for no change, measures from the 
ACT in light-to-moderate PA revealed that 18 subjects became less active and 12 more active. As 
per the SWA, 14 subjects became less active and 16 more active. Scores from the CHAMPS 
indicated that 16 subjects became less active and 14 more active. We also visually observed the 
number of subjects who changed beyond a magnitude that most clinicians would agree to be an 
important change (e.g., 20 min/day in light-to-moderate PA). Based on that, measures from the 
ACT revealed that 10 subjects became more active, 9 less active, and 11 did not change; based on 
the SWA, 11 subjects became more active, 13 less active, and 6 did not change; and based on the 
CHAMPS, 7 subjects became more active, 11 less active, and 12 did not change. Figure 16 shows 
the slopes of lines from baseline to follow-up for each individual subject.  
Internal responsiveness analyses demonstrated that none of the PA measurement tools 
detected significant group changes in PA from pre to post intervention (p≥0.163) for both duration 
of PA (Table 7) or caloric expenditure (Table 8). Additionally, the values of SRM ranged from 0.01 
to 0.26, indicating that the measurement tools had a trivial to small degree of responsiveness across 
PA categories.  
For external responsiveness, while the graphical representation of change in PA (Figure 15) 
indicated that similar number of subjects became less or more active, none of the subjects reported 
being less active based on the global rating of change in PA (Table 9). According to the global rating 
of change, 5 subjects (17%) reported having the same activity level at 6 months and the remaining 
25 subjects (83%) reported being at least a little bit more active. Consequently, the scores from the 
global rating of change in PA were not significantly correlated (rho from 0.05 to 0.28) with the 
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ACT: Actigraph; SWA: Sensewear Armband; CHAMPS:  Community Healthy Activities Model Program for Seniors questionnaire. 
Figure 15. Changes in physical activity (PA) duration measured by the ACT, SWA and CHAMPS questionnaire pre to post intervention 
across the three PA intensity categories, and number of steps (ACT and SWA only). Numbers on the Y-axis represent frequency and 
numbers on the X-axis represent PA duration in min/day. 
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Figure 16. Slopes of lines from baseline to follow-up across all physical activity categories measured 
by each instrument for each individual subject. 
 
 
changes in PA duration measured by any of the three instruments (Table 9). The correlations were 
similar and also not significant for measures of PA in caloric expenditure (Data not shown). Due to 
these poor correlations, ROC curves were not pursued.  
PA Categories ACTIGRAPH SENSEWEAR ARMBAND CHAMPS  
Light-to-
moderate PA 
(min/day) 
   
Light-
intensity PA 
(min/day) 
   
Moderate-
intensity PA 
(min/day) 
   
Number of 
steps/day 
  
Not applicable 
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Since results on PA duration were similar to those on PA caloric expenditure, for the 
comparison of responsiveness across the PA measurement tools we present data on PA duration 
only. Table 10 shows the comparison of magnitude of changes in PA duration between instruments. 
Results indicated no statistically significant differences across PA categories of the number of steps 
(p≥0.124). Moreover, it was observed that the 95% confidence interval of the SRMs across 
instruments largely overlapped (Tables 7 and 8). When the measurement error was used as a 
threshold for change in PA (Table 11), weighted Kappa (K) indicated moderate agreement between 
the ACT and SWA on identifying changes in PA that were beyond the standard error of the 
measurement in activities of moderate-intensity (K=0.60), good agreement in number of steps 
(K=0.63), and fair agreement in light-to-moderate PA (K=0.36), all of which were statistically 
significant. Agreement was fair between ACT and SWA in measures of light-intensity PA (K=0.25) 
as well as between ACT and CHAMPS in measures of light-to-moderate PA (K=0.22), but were not 
statistically significant. There was poor agreement between CHAMPS and the activity monitors in 
measures of light-to-moderate PA (K≤0.07) and light-intensity PA (K≤0.12). Agreement was also 
poor between CHAMPS and SWA in identifying changes in moderate-intensity PA (K=0.12). Table 
12 depicts the number of times the measurement tools agreed with each other on classifying 
individuals who had more, less or about the same level of PA using the measurement error as a 
threshold for change in PA. 
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Table 7. Duration of physical activity in min/day measured by the ACT, SWA and CHAMPS questionnaire, the magnitude of changes 
scores between baseline and follow-up, and the standardized response mean. Data represent mean±SD, unless otherwise indicated. 
Instrument PA categories Baseline Follow-up Change in PA P-value ‡ SRM (95% CI) 
ACT 
Light-to-moderate 
(min/day) 81.5±44.4 75.3±47.3 
-6.2±36.6 
95% CI: -19.9; 7.4 0.358 -0.17 (-0.50; 0.20) 
Light-intensity 
(min/day) 69.6±35.1 62.4±36.2 
-7.2 ±27.5 
95% CI: -17.5; 3.1) 0.163 -0.26 (-0.57; 0.11) 
Moderate-intensity 
(min/day) 11.9±13.4 12.6±16.2 
0.6±14.3 
95% CI: -4.7; 6.0 0.814 0.04 (-0.33; 0.40) 
Number of Steps 
(steps/day) 4676±2151 4667±2109 
9±1526 
95% CI: -607; 625 0.976 -0.01 (-0.35; 0.37) 
SWA 
Light-to-moderate 
(min/day) 163.6±104.7 158.6±108.3 
-5.0±70.5 
95% CI: -31.4; 21.3 0.698 -0.07 (-0.48; 0.23) 
Light-intensity 
(min/day) 119.3±77.4 117.1±88.8 
-2.3±60.2 
95% CI: -24.7; 20.3 0.844 -0.04 (-0.40; 0.33) 
Moderate-intensity 
(min/day) 44.2±37.8 41.4±36.7 
-2.8±37.0 
95% CI: -16.6; 11.1 0.686 -0.08 (-0.43; 0.29) 
Number of Steps 
(steps/day) 6003±3311 5960±2995 
-42.8±2266.3 
95% CI: -889.1; 803.5 0.918 -0.02 (-0.34; 0.37) 
CHAMPS 
Light-to-moderate 
(min/day) 121.7±70.4 110.1±53.4 
-11.6±64.6 
95% CI: -35.7; 12.6 0.335 -0.18 (-0.51; 0.19) 
Light-intensity 
(min/day) 68.4±57.9 67.0±37.5 
-1.4±46.0 
95% CI: -18.5; 15.8 0.870 -0.03 (-0.39; 0.33) 
Moderate-intensity 
(min/day) 53.4±33.3 44.2±31.8 
-9.1±46.5 
95% CI: -26.5; 8.2 0.290 -0.20 (-0.52; 0.17) 
ACT: Actigraph; SWA: Sensewear Armband; CHAMPS:  Community Healthy Activities Model Program for Seniors questionnaire; PA: 
physical activity; 95% CI: 95% confidence interval; ‡ p-values from analysis of the change scores between baseline and follow-up from 
Paired t-test; SRM: standardized response mean. 
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Table 8. Physical activity caloric expenditure in kcal/day measured by the ACT, SWA and CHAMPS questionnaire, the magnitude of 
changes scores between baseline and follow-up, and the standardized response mean. Data represent mean±SD, unless otherwise 
indicated. 
Instrument PA categories Baseline Follow-up Change in PA P-value ‡ SRM (95% CI) 
ACT 
Light-to-moderate 323.6±157.7 309.4± 190.9 -14.3±114.6 95% CI: -57.1; 28.6 0.501 -0.13 (-0.47; 0.24) 
Light 247.6±99.4 233.9±105.2 -13.7±66.2 95% CI: -38.5; 11.0 0.266 -0.21 (-0.53; 0.16) 
Moderate 76.0±86.0 75.5±112.5 -0.5±72.7 95% CI: -27.7; 26.6 0.969 -0.01 (-0.37; 0.35) 
SWA 
Light-to-moderate 573.4±351.1 557.8±356.5 -15.6±218.9 95% CI: -97.3; 66.1 0.699 -0.07 (-0.42; 0.30) 
Light 348.1±200.8 343.7± 234.8 -4.4±154.0 95% CI: -61.9; 53.1 0.876 -0.03 (-0.39; 0.33) 
Moderate 217.8±186.0 214.1± 198.4 -3.8±152.5 95% CI: -60.7; 53.2 0.894 -0.03 (-0.39; 0.33) 
CHAMPS 
Light-to-moderate 492.4±376.1 480.3±280.9 -12.2±289.4 95% CI: -120.2; 95.9 0.820 -0.04 (-0.40; 0.33) 
Light 217.0±110.7 227.9±119.9 10.9±115.7 95% CI: -32.3; 54.2 0.609 -0.09 (-0.43; 0.28) 
Moderate 275.4±328.4 252.4±235.7 -23.1±251.7 95% CI: -117.1; 70.9 0.619 -0.09 (-0.43; 0.28) 
95% CI: 95% confidence interval; ‡ p-values from analysis of the change scores between baseline and follow-up from Paired t-test. 
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Table 9. Change in duration of physical activity measured by the ACT, SWA and CHAMPS questionnaire across descriptors from the 
global rating of change, and the correlations between changes in PA measured by the instruments and scores from global rating of change. 
 ACT SWA CHAMPS 
Frequency of descriptors from the GRC-PA and measured changes in light-to-moderate PA in min/day. Median (Q25; Q75) 
About the same active (n=5) -15.6 (-72.0, 29.9) - 37.8 (-100.2, 65.7) 0.0 (-93.2, 27.9) 
A little bit more active (n=2) 4.3 (-22.0, 30.6) -18.7 (-29.2, -8.2) -15.0 (-32.1, 2.1) 
Somewhat more active (n=6) 12.0 (-18.1, 27.2) -17.2 (-29.7, 57.2) -15.0 (-65.9, 9.1) 
Moderately more active (n=5) -0.6 (-16.1, 0.8) -11.8 (-110.9, 29.1) -19.3 (-69.6, 0.0) 
Quite a bit more active (n=6) 0.6 (-30.6, 34.1) 59.2 (22.5, 90.6) 20.4 (-51.4, 51.4) 
A great deal more active (n=2) -44.6 (-66.4, -18.8) -69.1 (-694, -68.8) -70.7 (-177.9, 36.4) 
A very great deal more active (n=4) 21.4 (-26.8, 39.6) 9.7 (-82.3, 29.7) 18.2 (2.1, 108.2) 
Spearman's rho correlations between GRC-PA and changes in PA measured by the instruments 
Light-to-moderate PA (min/day) 0.15 0.28 0.14 
Light-intensity PA (min/day) 0.13 0.20 0.28 
Moderate-intensity PA (min/day) 0.05 0.07 0.21 
Number of Steps (min/day) 0.13 0.24 ----- 
ACT: Actigraph; SWA: Sensewear Armband; CHAMPS:  Community Healthy Activities Model Program for Seniors questionnaire; GRC-
PA: global rating of change in physical activity; Q25: quartile 25th; Q75: quartile 75th; 
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Table 10. Comparison of physical activity change scores across the three measurement tools at each intensity category. 
PA category 
Δ from ACT 
Mean ± SD 
Δ from SWA 
Mean ± SD 
Δ from CHAMPS 
Mean ± SD 
df F 
P-value¶ 
Light-to-moderate (min/day) 0.6 ± 14.3 -2.8 ± 37.0 -9.1 ± 46.5 1, 29 1.940 0.174¶ 
Light-intensity (min/day) -6.2 ± 36.6 -5.0 ± 70.5 -11.6 ± 64.6 1, 29 0.622 0.437¶ 
Moderate-intensity (min/day) -7.2 ± 27.5 -2.3 ± 60.2 -1.4 ± 46.0 1, 29 1.648 0.209¶ 
Number of Steps 9 ± 1526 -43 ± 2266 ----- ----- ----- 0.124§ 
ACT: Actigraph, SWA: Sensewear Armband; CHAMPS: Community Health Activities Model Program for Seniors; Δ: Changes in physical 
activity; df: degrees of freedom; F: F ratios from analysis of variance ¶: P-value: results from Analysis of Variance (ANOVA) between mean 
changes measured by the instruments; § P-value: results from paired samples t-test between changes in number of steps measured by the 
ACT and SWA; 
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Table 11. Number of subjects who were less active, more active, or did not change based on the standard error of the measurement, and 
weighted Kappa between measures of PA from the ACT, SWA and the CHAMPS questionnaire. 
PA 
Category 
 ACT 
n (%) 
SWA 
n (%) 
CHAMPS 
n (%) 
Weighted Kappa (95% CI) 
ACTxSWA SWAxCHAMPS CHAMPSxACT 
Light-to-
Moderate 
PA 
< SEM 11 (37%) 10 (33%) 12 (40%) 
0.36 
(0.09; 0.62)* 
-0.07 
(-0.33; 0.19) 
-0.04  
(-0.32; 0.24) 
No Δ 10 (33%) 11 (37%) 11 (37%) 
> SEM 9 (30%) 9 (30%) 7 (23%) 
Light-
intensity 
PA 
< SEM 12 (40%) 9 (30%) 10 (33%) 
0.25 
(-0.03; 0.52) 
-0.12 
(-0.37; 0.14) 
-0.02  
(-0.29; 0.26) 
No Δ 11 (37%) 16 (53%) 9 (30%) 
> SEM 7 (23%) 5 (17%) 11 (37%) 
Moderate-
intensity 
PA 
< SEM 7 (23%) 11 (37%) 11 (37%) 
0.60 
(0.38; 0.81)* 
0.12  
(-0.16; 0.40) 
0.22  
(-0.05; 0.49) 
No Δ 16 (53%) 10 (33%) 8 (26%) 
> SEM 7 (23%) 9 (30%) 11 (37%) 
Number 
of Steps 
< SEM 4 (13%) 9 (30%) ----- 
0.63 
(0.39; 0.86)* 
----- ----- No Δ 13 (43%) 10 (33%) ----- 
> SEM 9 (30%) 11 (37%) ----- 
ACT: Actigraph; SWA: Sensewear Armband; CHAMPS:  Community Healthy Activities Model Program for Seniors questionnaire; PA: 
physical activity; SEM: standard error of the measurement; n (%): number of subjects (percentage); * statistically significant with p<0.05; 
<SEM: less active based on SEM; >SEM: more active based on SEM; No Δ: No changes in PA based on SEM.  
SEM for the ACT is: LPA (13.0 min/day), MPA (5.3 min/day), LMPA (16.9 min/day) and number of steps (709 steps/day). 
SEM for the SWA is: LPA (22.5 min/day), MPA (10.8 min/day), LMPA (29.8 min/day) and number of steps (937 steps/day). 
SEM for the CHAMPS is: LPA (12.9 min/day), MPA (12.2 min/day) and LMPA (16.8 min/day). 
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Table 12. Agreement between measurement tools based on results from weighted Kappa. The diagonal line in bold font represents the 
number of times the instruments agreed on classifying individuals who were more, less or about the same active. 
PA Categories ACT (yellow) x SWA (orange) ACT (yellow) x CHAMPS (orange) CHAMPS (yellow) x SWA (orange) 
Light-to-moderate PA 
   
Light-intensity PA 
   
Moderate-intensity PA 
   
Number of steps 
 
  
worse same better Total
worse 5 5 1 11
same 3 4 3 10
better 1 2 6 9
Total 9 11 10 30
worse same better Total
worse 4 4 3 11
same 5 4 1 10
better 3 4 2 9
Total 12 12 6 30
worse same better Total
worse 3 5 4 12
same 4 3 4 11
better 2 3 2 7
Total 9 11 10 30
worse same better Total
worse 5 5 1 11
same 5 5 2 12
better 0 4 3 7
Total 10 14 6 30
worse same better Total
worse 3 3 5 11
same 5 4 3 12
better 2 2 3 7
Total 10 9 11 30
worse same better Total
worse 2 5 3 10
same 4 4 1 9
better 4 5 2 11
Total 10 14 6 30
worse same better Total
worse 5 2 0 7
same 5 8 3 16
better 0 0 7 7
Total 10 10 10 30
worse same better Total
worse 3 2 2 7
same 7 5 4 16
better 1 1 5 7
Total 11 8 11 30
worse same better Total
worse 3 6 2 11
same 4 2 2 8
better 3 2 6 11
Total 10 10 10 30
worse same better Total
worse 3 2 0 5
same 4 10 2 16
better 0 1 8 9
Total 7 13 10 30
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3.5 DISCUSSION 
This is the first study to determine and compare the responsiveness of the ACT, SWA, and 
CHAMPS in assessing PA from light to moderate intensities after rehabilitation following TKA. 
Results of this study indicate that although a good number of subjects increased, decreased or did 
not change PA participation from baseline to follow-up, when changes in PA were measured at the 
group level they were small and not statistically significant. Thus, the ACT, SWA and the CHAMPS 
demonstrated similar trivial to small degree of internal responsiveness. Furthermore, subjects’ 
perception of changes in PA did not correlate with changes in PA measured by the three 
instruments and precluded the determination of thresholds of clinically important changes. Study 
results also demonstrate that when using the standard error of the measurement as a threshold for 
changes in PA at the individual-level, the two activity monitors (ACT and SWA) demonstrated good 
agreement in identifying changes in PA that were beyond measurement error, whereas the measures 
of change from the portable devices did not agree with information from the self-reported 
questionnaire (CHAMPS).  
Results from our study agree with prior studies that assessed the responsiveness of the ACT 
and CHAMPS and reported trivial to small degree of responsiveness in those PA measurement 
tools. 44,138-140 Lee et al. evaluated the responsiveness of the ACT during a telephone delivered weight 
loss intervention that promoted PA and dietary change in individuals with type-2 diabetes (20 to 77 
years old) and found a SRM of 0.24 for measures of moderate-intensity PA.138 Swartz et al. 
determined the responsiveness of the ACT in sedentary healthy adults (21 to 67 years old) during an 
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intervention to reduce sitting time and found a SRM of 0.18 for activities performed at 1 to 1.9 
METs, 0.19 for activities at 2 to 2.9 METs, and 0.30 for activities above 3 METs. 140 Gardiner et al. 
determined the responsiveness of the ACT in detecting sedentary time in nonworking older adults 
(average age 73 years old), and found an effect size of 0.36 after an intervention that targeted a 
reduction of sedentary time. 139 One study investigated the responsiveness of the CHAMPS 
questionnaire in healthy older adults (65 to 90 years old) during interventions to increase PA 
participation and found effect sizes of 0.33 and 0.37 for measures of moderate-intensity PA and 
light-to-moderate PA respectively. 44  
Investigating responsiveness of measures of PA in older adults with arthritis of the lower 
extremities is challenging due to the difficulty in promoting changes in lifestyle and the high 
variability in PA measures, both of which lead to small effect sizes. To assess responsiveness of 
measures of PA, regardless of the population, seems problematic because of the inherent difficulty 
to promote changes in PA behavior. A recent meta-analysis assessed the overall effectiveness of 
interventions designed to increase PA in 3,643 healthy older adults included in 33 studies.39 These 
studies used a pretest-posttest design and assessed PA utilizing a variety of methods, including 
activity monitors and questionnaires such as the ACT, SWA and CHAMPS. The authors reported a 
small pooled effect size of 0.23 (95% CI: 0.15; 0.31),39 indicating only minimal changes in activity 
behavior. Thus, the development of interventions able to promote substantial changes in activity 
behavior is warranted. Recently, funding agencies such as the National Institute of Health have 
issued announcements seeking innovative interventions to increase PA participation. In terms of 
high variability in the PA measures, the coefficient of variation for change scores (i.e., ratio of 
standard deviation to the mean) was very high in our study and across the studies that reported 
responsiveness indices of the ACT and CHAMPS (cited above).44,138-140 The coefficients of variation 
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ranged from 3 to 33 times the mean for change in duration of PA and from 53 to 170 times the 
mean for change in number of steps. The higher coefficient of variation for changes in number of 
steps is because the mean change for the group was very small in comparison to the variability of the 
change. Since variability serves as the numerator of the equation, it resulted in enormous coefficients 
of variation. The large variability in change scores can be attributed to the fact that about 1/3 of the 
subjects became more active, 1/3 became less active, and 1/3 did not change their PA participation 
at follow-up. Consequently, the instruments were not able to detect changes at the group-level, 
which makes the utilization of methods that investigate changes in PA at the individual-level more 
appealing. 
In this study we attempted to assess responsiveness at the individual-level using a modified 
global rating of change as an external anchor. However, changes perceived by the subjects had only 
poor to small correlations with changes in PA measured by the three instruments. We believe that 
the lack of correlation between perceived and measured changes in PA is partially due to social 
desirability bias.143 When completing the global rating of change in PA after the intervention, 
subjects tended to respond to the question in a socially acceptable direction. This tendency may have 
led to an overstatement of changes in PA participation since none of them reported less PA. 
Although our research team diligently attempted to decrease social desirability bias by instructing the 
subjects to provide honest and objective answer on changes in PA after the intervention, it seems 
that it was not enough to prevent that. In addition, the small correlations may also be a result of the 
difficulty that subjects have in adjudicating changes in the amount of activities during a long period 
of time (6 months) used in this study. The perception of change in PA participation over 6 months 
may be particularly difficult for older adults with knee osteoarthritis because they usually engage 
mainly in light-intensity PA and this type of PA has been shown to be the most difficult to recall.144 
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We are not aware of any studies that attempted to use external responsiveness methods to 
investigate sensitivity of change of the ACT, SWA or CHAMPS to compare our results for external 
responsiveness.  
An alternative to assess changes in PA at the individual-level is the use of the standard error 
of the measurement as a threshold. Using this approach was a practical step taken to identify 
changes in PA that were above measurement error, which might be appropriate in situations where 
patient-perceived changes are unavailable.145 While measurement error has been used as a threshold 
in many studies that investigated changes in other outcomes 146,147 this is the first study to discuss 
changes in PA behavior based on measurement error. By using this approach, we were able to test 
the agreement between PA measurement tools in classifying individuals who did or did not change 
their PA participation. While the ACT and SWA generally agreed on classifying those who changed, 
the activity monitors disagreed with PA changes measured by the CHAMPS. This discrepancy may 
have been due to limitations inherent of PA questionnaires such as recall-bias.48,119  
A weakness of this study is the small sample size. Although this study has a relatively small 
sample size, it is unlikely that the non-significant results for internal responsiveness were due to type 
2 error because the changes in PA were all very small. As discussed above, these small changes were 
likely the results of difficulties in changing subjects’ lifestyle along with high variability in change 
scores. Therefore, to properly assess the responsiveness of PA measures when there is no warranty 
that the construct of PA will change, future studies in older adults with arthritis of the lower 
extremity could be performed in a controlled environment. A recent study assessed the 
responsiveness of the ACT in children and adolescents (6-16 year of age) who performed low- and 
high-intensity activities in a simulated free-living setting.148 Their results showed that the ACT had a 
high degree of responsiveness to capture changes from low- to high-intensity activities (SRM≥1.1).  
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3.6 CONCLUSION 
Our study showed that, although the ACT, SWA and CHAMPS had small degrees of 
responsiveness, the activity monitors (ACT and SWA) agreed on detecting changes in PA when 
measurement error was used as a threshold. Therefore, when investigating changes in PA behavior 
in individuals with arthritis of the lower extremities, clinicians and researchers should consider the 
alternative to interpret their results based on changes that occurred beyond measurement error, since 
those changes may not be detectable at a group-level.  
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4.0 CHAPTER 4 - SIGNIFICANCE AND DIRECTION OF FUTURE RESEARCH 
The focus of this dissertation was to investigate and concurrently compare the psychometric 
properties of three instruments to measure PA in older adults with knee osteoarthritis who 
underwent TKA. Chapter 1 presented the gaps in knowledge, relevance of our investigation, and 
methods and procedures proposed in this dissertation. Chapter 2 described the study that 
investigated the reliability of the ACT, SWA and CHAMPS questionnaire in measuring PA in free-
living condition. Results indicated that the three instruments were highly reliable. However, the 
magnitude of PA measures from the ACT were significantly lower compared to the SWA across 
intensity categories; the CHAMPS showed systematic bias in measures of light-intensity PA; and the 
SWA showed better precision amongst the three PA measurement tools. Also, this study provided 
information on the reliability of the activity monitors in measuring PA during different timeframes. 
Measuring PA during wake-hours (i.e., time between getting out of bed in the morning to going back 
to bed at night) seems to be the most appropriate timeframe to measure PA. Measures of PA taken 
during wake-hours are highly reliable, provide a good representation of daily activities in comparison 
to 24-hours timeframe, and may help reduce the burden on subjects when wearing activity monitors. 
Chapter 3 described the study that assessed the responsiveness of the ACT, SWA and 
CHAMPS after exercise programs in subjects who underwent TKA. Results from this study 
indicated that the three instruments have similarly low degrees of responsiveness. Our findings 
showed that assessing responsiveness at the group-level is less than ideal since changing PA 
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behavior is very difficult and the variability in the data for change scores is very large, both of which 
result in small effect sizes. Also, we found that using an anchor based on self-reported changes in 
PA was not feasible since its scores did not correlate with changes assessed by the PA measurement 
tools. In that study, we proposed an alternative to investigate changes in PA at the individual-level 
by using the standard error of the measurement as a threshold for changes in PA. This approach is 
practical as it can be used to identify changes in PA for individual patients.  
Validity is also an important aspect of the psychometrics of a measurement instrument. 
Although not part of my dissertation, during my PhD training I investigated the concurrent 
criterion-related validity of the ACT and SWA in comparison to the criterion method of indirect 
calorimetry. 84 Twenty-one older adults who underwent TKA participated in an 80-minute protocol 
that included 9 increasingly demanding activities in a laboratory setting. Energy expenditure was 
concurrently estimated by the activity monitors and the indirect calorimetry throughout the 
protocol. Our results indicated that the ACT underestimated the values of energy expenditure by 
40% to 100% in comparison to the criterion method. The differences between the SWA and the 
criterion were small, not greater than 19%. Also, the SWA was able to accurately assess non-walking 
activities (i.e., lying down, sit and read, computer-work, stand and talk, stand and load shelves, and 
mopping), while the ACT was not. Overall, the SWA showed better criterion-related validity than 
the ACT to measure PA in older adults with knee osteoarthritis who underwent TKA. 
Based on the combined results from my studies on the psychometric properties (reliability, 
criterion-related validity, and responsiveness) of the ACT, SWA and CHAMPS, it seems that in 
general the activity monitors are a better choice than the CHAMPS questionnaire to measure PA in 
older adults with arthritis of the lower extremities. Although the ACT and SWA are costly in 
comparison to the CHAMPS, the questionnaire was susceptible to recall bias and did not agree with 
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the activity monitors in the identification of patients who changed versus those who did not change 
PA participation. However, it is important to mention that the recall bias occurred for light-intensity 
PA only, and that the reliability of measures of light-to-moderate and moderate-intensity PA from 
the CHAMPS was high and comparable to the reliability of the SWA in those PA categories. 
Therefore, the CHAMPS may be useful to assess light-to-moderate and moderate-intensity PA in 
cross-sectional studies since its responsiveness to interventions seems to be limited. Amongst the 
activity monitors, the SWA seems to be the best option. The SWA showed better accuracy and 
reliability than the ACT. In particular, the SWA has been shown to be capable of accurately and 
reliably capture light-intensity activities, such as slow walking and tasks that do not involve 
ambulation, which are usually performed by individuals with arthritis of the lower extremities. The 
significance of these series of studies is that they provide evidence for a well-educated choice of 
measurement tools to be used when assessing PA in this population and will help to interpret data 
on changes in PA in future trials targeting PA promotion to increase activity participation. 
From the time when we proposed these studies to date, newer accelerometry-based activity 
monitors have been released in the market. These devices are much cheaper and smaller than the 
ones used in this study. Some examples are the BodyMedia FIT, Fitbit, Jawbone Up, NikeFuel band, 
iFit, Runtastic Orbit, Garmin Vivosmart, and more. Since these activity monitors are usually wrist-
mounted and a few are waterproof, they can decrease patients’ burden when measuring their daily 
PA. In addition, numerous applications for smartphones have been developed and refined over the 
years. Although all these new activity monitors and mobile apps have been developed to attract the 
general public, future research studies should test their psychometric properties to provide insights 
on appropriateness to specific populations. 
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By conducting these studies I acquired comprehensive and in depth understanding of 
measures of PA and confirmed with my own data that changing activity behavior in older adults is 
challenging. I plan to use this knowledge to transition into a different but related area of research 
that entails the development of interventions to promote PA. For many years the world health 
organization has highlighted the need for developing interventions to increase PA participation. 
While recent systematic reviews and meta-analysis identified several types of PA promotion 
interventions, they showed only small treatment effects, 149,150 which warrants refinement of those 
interventions. The development of innovative and effective interventions to promote PA is currently 
the focus of several funding institutions such as the National Institute of Health and several 
Foundations. The world health organization is targeting for a reduction of 10% in physical inactivity 
by 2025. Therefore, my plan is to take advantage of this momentum in research to develop 
innovative interventions to promote PA that may impact health in individuals with arthritis. 
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